WO2004000159A2 - Metal back or mesh crosslinking - Google Patents

Metal back or mesh crosslinking Download PDF

Info

Publication number
WO2004000159A2
WO2004000159A2 PCT/US2003/018053 US0318053W WO2004000159A2 WO 2004000159 A2 WO2004000159 A2 WO 2004000159A2 US 0318053 W US0318053 W US 0318053W WO 2004000159 A2 WO2004000159 A2 WO 2004000159A2
Authority
WO
WIPO (PCT)
Prior art keywords
polyethylene
carried out
interface
metallic
heating
Prior art date
Application number
PCT/US2003/018053
Other languages
French (fr)
Other versions
WO2004000159A3 (en
Inventor
Orhun K. Muratoglu
William H. Harris
Original Assignee
Massachusetts General Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts General Hospital filed Critical Massachusetts General Hospital
Priority to US10/518,593 priority Critical patent/US20050146070A1/en
Priority to AU2003245420A priority patent/AU2003245420A1/en
Publication of WO2004000159A2 publication Critical patent/WO2004000159A2/en
Publication of WO2004000159A3 publication Critical patent/WO2004000159A3/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/003Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor characterised by the choice of material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30965Reinforcing the prosthesis by embedding particles or fibres during moulding or dipping
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • A61L2/081Gamma radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • A61L2/087Particle radiation, e.g. electron-beam, alpha or beta radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/14Plasma, i.e. ionised gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20Gaseous substances, e.g. vapours
    • A61L2/206Ethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/34Acetabular cups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/38Joints for elbows or knees
    • A61F2/3804Joints for elbows or knees for elbows
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/38Joints for elbows or knees
    • A61F2/3877Patellae or trochleae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/38Joints for elbows or knees
    • A61F2/389Tibial components
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/40Joints for shoulders
    • A61F2/4081Glenoid components, e.g. cups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/42Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
    • A61F2/4202Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for ankles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/42Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
    • A61F2/4241Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for hands, e.g. fingers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/3082Grooves
    • A61F2002/30823Grooves having the shape of a reverse dovetail
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/3082Grooves
    • A61F2002/30827Plurality of grooves
    • A61F2002/30828Plurality of grooves parallel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30878Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
    • A61F2002/30891Plurality of protrusions
    • A61F2002/30892Plurality of protrusions parallel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30942Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • A61F2002/30957Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques using a positive or a negative model, e.g. moulds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2002/3208Bipolar or multipolar joints, e.g. having a femoral head articulating within an intermediate acetabular shell whilst said shell articulates within the natural acetabular socket or within an artificial outer shell
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/46Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2002/4631Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor the prosthesis being specially adapted for being cemented
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00395Coating or prosthesis-covering structure made of metals or of alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20Targets to be treated
    • A61L2202/24Medical instruments, e.g. endoscopes, catheters, sharps
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2023/00Use of polyalkenes or derivatives thereof as moulding material
    • B29K2023/04Polymers of ethylene
    • B29K2023/06PE, i.e. polyethylene
    • B29K2023/0658PE, i.e. polyethylene characterised by its molecular weight
    • B29K2023/0683UHMWPE, i.e. ultra high molecular weight polyethylene
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/25Solid
    • B29K2105/253Preform
    • B29K2105/256Sheets, plates, blanks or films
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2705/00Use of metals, their alloys or their compounds, for preformed parts, e.g. for inserts
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00Other particular articles
    • B29L2031/753Medical equipment; Accessories therefor
    • B29L2031/7532Artificial members, protheses

Definitions

  • the present invention relates to a medical implant that comprises polymeric material that is in contact (which includes close proximity and touching) with another piece (such as a metallic mesh or back, a non-metallic mesh or back, a tibial tray, a patella tray, or an acetabular shell), thereby forming an interface.
  • another piece such as a metallic mesh or back, a non-metallic mesh or back, a tibial tray, a patella tray, or an acetabular shell.
  • crosslink density in polyethylene is desired in bearing surface applications for joint arthroplasty because it significantly increases the wear resistance of this material.
  • the preferred method of crosslinking is by exposing the polyethylene to ionizing radiation.
  • ionizing radiation in addition to crosslinking, also will generate residual free radicals, which are the precursors of oxidation-induced embrittlement. This is known to adversely affect in vivo device performance. Therefore, it is desirable to reduce the concentration of residual free radicals, preferably to undetectable levels, following irradiation so as to avoid long-term oxidation.
  • U.S. Patent No. 5,897,400 Methods of irradiating polymers are described in U.S. Patent No. 5,897,400.
  • this patent describes medical prosthesis formed, at least in part, of a melt- irradiated crosslinked high molecular weight polyethylene.
  • the disclosed melt- irradiation process improves the wear resistance of the polymer, thus addressing the problem of severe adverse effects associated with the use of less wear resistant polymers.
  • U.S. Patent No. 5,897,400 describes, among other things, heating the polymers to or above the melting point, irradiating the polymer, and cooling the polymer.
  • WO 97/29793 also describes methods of irradiating polymers in which the heat generated by the irradiation is sufficient to at least partially melt the polymer, and is described as "adiabatic" melting or heating.
  • Adiabatic melting or heating refers to heating induced by radiation, which leads to an increase of the temperature of the polymer with substantially little loss of heat to the surroundings.
  • the application describes an adiabatic melting method, among other things, in which the polymer is preheated to a temperature below the melting point, then irradiated with enough total dose and at a high enough dose rate to at least partially melt the polymer crystals. Subsequent to this warm-irradiation, the polymer also can be heated to or above the melting temperature such that any residual free radicals are eliminated.
  • the application also describes another irradiation, adiabatic melting method that is similar to the method described above, except that the polymer is provided at room temperature or below.
  • UHMWPE ultra-high molecular weight polyethylene
  • sterilization can be utilized for medical implants, such as the use of ethylene oxide, gas plasma, heat (autoclave), or radiation.
  • heat applying heat to a packaged polymeric medical product can destroy either the integrity of the packaging material (particularly the seal, which is provided to prevent bacteria and other contaminants from entering the package after the sterilization step) or the product itself.
  • ethylene oxide may adversely impact environmental and employee safety
  • gamma ray, x-ray or electron beam radiation has been utilized as a preferred means of sterilization.
  • These types of radiation use a high- energy beam to destroy or inactivate bacteria, viruses, and other microbial species that contaminate the packaged medical products.
  • the high- energy beam causes generation of free radicals in polymers during irradiation. It also has been recognized that the amount of free radicals generated is dependent upon the radiation dose received by the polymers and that the distribution of free radicals in the polymeric implant depends upon the geometry of the component, the type of polymer, the dose rate, and the type of radiation.
  • EtO and GP are successfully used in sterilizing certain polymeric implants, despite environmental and safety concerns, there are some implant designs where these gas sterilization methods will not work.
  • These medical implants often contain factory-assembled pieces (usually a metallic or ceramic component) that are in close contact with the UHMWPE. In most cases, the interface is not accessible to the EtO gas or the GP. Therefore, these implants must be sterilized by gamma radiation, in air or in inert atmospheres. Yet these methods generate enough residual free radicals to adversely affect device performance in the long-term.
  • the current invention therefore, provides improved methods of making and sterilizing medical implants that contains highly cross-linked polymeric material, wherein the polymeric component (for example, UHMWPE) is in close contact with another piece (such as another component, for example, a metallic or a non-metallic component).
  • the polymeric component for example, UHMWPE
  • another piece such as another component, for example, a metallic or a non-metallic component.
  • the present invention relates generally to methods of manufacturing and sterilizing medical implants comprising a polymeric material, such as cross-linked ultra-high molecular weight polyethylene (UHMWPE), that is in contact with another piece (generally a metallic piece), thereby forming an interface, for example, an interlocking interface.
  • a polymeric material such as cross-linked ultra-high molecular weight polyethylene (UHMWPE)
  • UHMWPE ultra-high molecular weight polyethylene
  • the invention provides methods of making a medical implant containing crosslinked polyethylene, for example, ultra-high molecular weight polyethylene (UHMWPE) that is in contact with another piece, thereby forming an interface, comprising the steps of: a) compression molding of polyethylene, including powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the crosslinked polyethylene by heating the hybrid material above the melting point of the crosslinked polyethylene.
  • Polyethylene sheets also can be employed, but they may not result in the attainment of interlocking interfaces.
  • the metallic or non-metallic back or mesh as described, in one aspect of the invention is shaped to serve as a fixation interface with the bone, through either bony growth or by bone cement, wherein the shapes are in the form of acetabular liner, tibial tray for total or unicompartmental knee implants, patella tray, glenoid component, ankle, elbow or finger component.
  • the invention includes methods of making a medical implant containing crosslinked polyethylene, for example, UHMWPE, that is in contact with another piece, thereby forming an interface, wherein the polyethylene, including powder, flakes and particles are compression molded to a metallic mesh, wherein the metallic mesh is shaped to serve as a fixation interface with the bone, through either bony growth or by bone cement, wherein the shapes are, for example, in the form of acetabular liner, tibial tray for total or unicompartmental knee implants, patella tray, glenoid component, ankle, elbow or finger component.
  • crosslinked polyethylene for example, UHMWPE
  • the polyethylene as described herein, is in contact with another piece, thereby forming an interface, for example, an interlocking interface, wherein the interface is rendered substantially sterile.
  • the invention provides methods of making medical devices including bipolar hip replacements, tibial knee inserts with reinforcing metallic and polyethylene posts, and an implant that contains an interface that cannot be sterilized by a gas sterilization method.
  • the invention provides medical implants manufactured by the methods described herein.
  • the invention provides methods of: sterilizing a medical implant containing crosslinked polyethylene that is in contact with another piece, thereby forming an interface, wherein the methods comprise the steps of a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; c) reducing free radicals in the crosslinked polyethylene by heating the hybrid material above the melting point of the crosslinked polyethylene; and d) sterilizing the medical implant with a gas.
  • Another aspect of the present invention includes methods of sterilization, wherein the implants are further sterilized by a gas, wherein the gas is ethylene oxide, gas plasma, or the other gas, wherein ethylene oxide, gas plasma, or the other gas, is used for gas sterilization.
  • the invention provides medical implants, comprising crosslinked polyethylene that is in contact with another piece, thereby forming an interface, made by processes comprising the steps of: a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the crosslinked polyethylene by heating the hybrid material above the melting point of the crosslinked polyethylene.
  • the invention provides interfaces made by processes comprising the steps of: a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the polyethylene by heating the hybrid material above the melting point of the polyethylene.
  • the invention provides interfaces made by processes comprising the steps of: a) compression molding of polyethylene to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the polyethylene by heating the hybrid material above the melting point of the polyethylene.
  • the invention provides interfaces made by processes comprising the steps of: a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; and b) irradiating the hybrid material by ionizing radiation, wherein the interface is rendered substantially sterile.
  • the invention provides interfaces made by processes comprising the steps of: a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the polyethylene by heating the hybrid material above the melting point of the polyethylene, wherein the interface is rendered substantially sterile.
  • the invention provides interfaces made by processes comprising the steps of: a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the polyethylene by heating the hybrid material above the melting point of the polyethylene, wherein the interface is rendered substantially sterile.
  • the invention provides acetabular assemblies comprising: a) polyethylene powder compression molded to another piece, thereby forming an interlocked hybrid material; b) a substantially sterile interface; and c) a metallic back.
  • the invention provides acetabular assemblies comprising: a) a polyethylene acetabular liner compression molded to another piece, thereby forming a mechanically interlocked hybrid material; b) a substantially sterile interface; and c) a metallic back.
  • Another aspect of the invention provides medical implants comprising crosslinked polyethylene having substantially no detectable free radicals; and at least one substantially sterile interface, for example, a substantially sterile mechanically interlocking interface.
  • Another aspect of the invention provides medical implants comprising crosslinked polyethylene having substantially no detectable free radicals; and a sterile mechanically interlocking interface, wherein polyethylene, such as resin powder, flakes and particles are compression molded to another piece, for example, a metallic mesh or back, a non-metallic mesh or back such as ceramic mesh or back, a tibial tray, a patella tray, or an acetabular shell.
  • polyethylene such as resin powder, flakes and particles are compression molded to another piece, for example, a metallic mesh or back, a non-metallic mesh or back such as ceramic mesh or back, a tibial tray, a patella tray, or an acetabular shell.
  • the heating temperature of the compressed polyethylene or the hybrid components are above the melting point of the polyethylene, preferably above about 137°C and the radiation dose at the melt is between about 25 kGy and about 1000 kGy.
  • the radiation dose can be about 50 kGy, about 100 kGy, about 200 kGy, about 300 kGy, about 400 kGy, about 500 kGy, about 600 kGy, about 700 kGy, about 800 kGy, about 900 kGy, or about 1000 kGy.
  • the heating of the hybrid material above the melting point of the polyethylene is carried out in air, wherein the air contains between about 1% and about 22% oxygen. In a preferred aspect of the invention, the heating is carried out in air containing between about 2% and about 21% oxygen.
  • the heating of the hybrid material above the melting point of the polyethylene is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
  • the heating of the hybrid material above the melting point of the polyethylene is carried out in a vacuum.
  • the counterface piece as described, in one aspect of the invention comprises a metal or a non-metal, wherein the piece is a metallic mesh or back, a ceramic mesh or back, a tibial tray, a patella tray, or an acetabular shell, wherein the piece comprises a metallic mesh or back, a non-metallic mesh or back, an undercut, a recess or a combination thereof.
  • the interfaces as described in one aspect of the invention comprise a metal- polymer, wherein the polymer is a polyolefin, wherein the polyolefin is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
  • the polymer is a polyolefin, wherein the polyolefin is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
  • UHMWPE ultra-high molecular weight polyethylene
  • the invention provides methods of sterilization, wherein the implant comprises medical devices selected from the group consisting of bipolar hip replacements, tibial knee inserts with reinforcing metallic and polyethylene posts, and an implant that contains an interface that cannot be readily sterilized by a gas sterilization method.
  • the ionizing radiation includes gamma or ionizing irradiation in air, wherein the air contains between about 1% and about 22% oxygen. In a preferred aspect of the invention, the radiation is carried out in air containing between about 2% and about 21% oxygen.
  • the ionizing radiation includes gamma or ionizing irradiation in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
  • the ionizing radiation includes gamma or ionizing irradiation in a vacuum.
  • the reduction of free radicals in the crosslinked polyethylene is achieved by heating the implants to above the melting temperature of the polyethylene, wherein the polyethylene can be in contact with a non-oxidizing medium, wherein the non-oxidizing medium is an inert gas or an inert fluid, wherein the medium is a polyunsaturated hydrocarbon selected from the group consisting of: acetylenic hydrocarbons such as acetylene; conjugated or unconjugated olefinic hydrocarbons such as butadiene and (meth)acrylate monomers; and sulphur monochloride with chloro-tri-fluoroethylene (CTFE) or acetylene.
  • CTFE chloro-tri-fluoroethylene
  • the reduction of free radicals in crosslinked polyethylene is achieved in air, wherein the air contains between about 1 % and about 22% oxygen.
  • the radiation is carried out in air containing between about 2% and about 21% oxygen.
  • the reduction of free radicals in crosslinked polyethylene is achieved in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
  • the reduction of free radicals in crosslinked polyethylene is achieved in a vacuum.
  • the invention provides medical implants comprising crosslinked polyethylene having substantially no detectable free radicals; and a sterile interface such as a mechanically interlocking interface.
  • the polyethylene of the implant as described herein is in contact with another piece, thereby forming an interface, wherein the polyethylene, such as resin powder, flakes and particles are compression molded to another piece, for example, a metal or a non-metal, thereby forming a mechanically interlocked hybrid material.
  • the implant as described herein is compression molded, wherein polyethylene, such as resin powder, flakes and particles are compression molded to another piece, for example, a metallic mesh or back, or a non-metallic mesh or back such as a ceramic mesh or back, a tibial tray, a patella tray, or an acetabular shell.
  • the implant as described herein comprises a metal-polymer interface, wherein the metal piece comprises a metallic mesh or back, or a non-metallic mesh or back such as a ceramic mesh or back, an undercut, a recess or a combination thereof, thereby forming a mechanically interlocked hybrid material.
  • Figures 1 shows sequential steps in compression molding of polyethylene powder (10) to a metallic mesh (20).
  • Figure 3 shows compression molding of polyethylene (120) on a metal shell (100) containing metallic mesh (20).
  • Figure 4 shows metallic tray (40) having mesh (20).
  • Figure 6 shows a schematic diagram of compression apparatus set up.
  • Figure 7 depicts a typical mesh incorporated into UHMWPE pin by high temperature compression.
  • Figure 9 depicts an example of mesh retention in the polyethylene resin/mesh assembly following irradiation and subsequent melting, that is post-irradiation before melting.
  • Figure 10 depicts an example of mesh retention in the polyethylene resin/mesh assembly following irradiation and subsequent melting, that is post-irradiation after melting.
  • the present invention relates generally to methods of manufacturing and sterilizing medical implants comprising a polymeric material, such as cross-linked ultra-high molecular weight polyethylene (UHMWPE), that is in contact with another piece (for example, a metallic or non-metallic component), thereby forming an interlocking interface.
  • a polymeric material such as cross-linked ultra-high molecular weight polyethylene (UHMWPE)
  • UHMWPE ultra-high molecular weight polyethylene
  • One aspect of the invention relates to the following processing steps to fabricate medical devices made out of highly crosslinked UHMWPE and containing metallic pieces such as bipolar hip replacements, tibial knee inserts with reinforcing metallic and polyethylene posts, and for any implant that contains a surface that cannot be readily sterilized by a gas sterilization method.
  • the UHMWPE component of a medical implant is in close contact with another material (such as a metallic mesh or back, a non-metallic mesh or back, a tibial tray, a patella tray, or an acetabular shell), wherein polyethylene, such as resin powder, flakes and particles are directly compression molded to these counterfaces.
  • a polyethylene tibial insert is manufactured by direct compression molding of polyethylene resin powder to a tibial tray, to a metallic mesh or back or to a non-metallic mesh or back.
  • the mesh is shaped to serve as a fixation interface with the bone, through either bony in-growth or the use of an adhesive, such as PMMA bone cement.
  • acetabular liner for total or unicompartmental knee implants
  • patella tray for total or unicompartmental knee implants
  • glenoid component ankle, elbow or finger component.
  • One aspect of the invention relates to mechanical interlocking of the molded polyethylene with the other piece(s), for example, a metallic or a non- metallic piece, that makes up part of the implant.
  • Another aspect of the invention provides methods for achieving mechanically interlocked medical devices.
  • a mesh-like surface on the other side facing the polyethylene powder is compression molded and the consolidated polyethylene takes a shape at the interface that penetrates into the mesh.
  • the mesh surface on the other side can be continuous through the interface or intermittent (see Figure 1).
  • Another aspect of the invention includes surfaces with geometries, for example, undercuts, grooves (see Figures 4-5), or the like that allows the polyethylene, such as resin powder, flakes and particles to penetrate, consolidate and . take the shape of the surface such that the mechanical interlocking achieved allows for a strong interface (see Figure 4).
  • Another aspect of the invention provides combination of interface surfaces, for example, a mesh and macro-geometries are combined to tailor an interface of preferred strength (see Figure 2).
  • the interface geometry is crucial in that polyethylene assumes the geometry as its consolidated shape.
  • UHMWPE has a remarkable property of 'shape memory' due to its very high molecular weight that results in a high density of physical entanglements.
  • plastic deformation introduces a permanent shape change, which is almost completely reversed by melting. This recovery of the original consolidated shape is due to the 'shape memory', which is triggered by melting.
  • the hybrid component is irradiated using ionizing radiation to a desired dose level, for example, about 25 kGy to about 1000 kGy, preferably between about 50 kGy and about 100 kGy.
  • a desired dose level for example, about 25 kGy to about 1000 kGy, preferably between about 50 kGy and about 100 kGy.
  • the invention discloses that while the irradiation crosslinks the polymer, it also sterilizes the interfaces, that is the close contact between the polyethylene and the counterface.
  • the irradiation step generates residual free radicals and therefore, a melting step is introduced thereafter to quench the residual free radicals. Since the polyethylene is consolidated into the shape of the interface, thereby setting a 'shape memory' of the polymer, the polyethylene does not separate from the counterface.
  • a non-oxidizing medium such as inert gas or inert fluid
  • the medium is heated to above the melting point of the irradiated polyethylene, for example, UHMWPE (above about 137°C) to eliminate the crystalline matter and to allow the recombination/elimination of the residual free radicals.
  • Another aspect of the invention provides that following the above steps of free radical elimination, the interface between the metal and the polymer become sterile due to the high irradiation dose level used during irradiation.
  • the device surface can be further machined to remove the oxidized surface layer.
  • the invention provides that in the case of a post-melting machining of an implant, the melting step is carried out in the presence of an inert gas.
  • Another aspect of the invention includes methods of sterilization of the fabricated device, wherein the device is further sterilized with ethylene oxide, gas plasma, or the other gases, when the interface is sterile but the rest of the component is not.
  • compression molding as referred herein related generally to what is known in the art and specifically relates to molding applicable in polyethylene-based devices, for example, medical implants wherein polyethylene in any physical state, including powder form, is compressed to solid support, for example, a metallic back, metallic mesh, or metal surface containing grooves, undercuts, or cutouts.
  • the compression molding also includes high temperature compression molding of polyethylene at various states, including resin powder, flakes and particles, to make a component of a medical implant, for example, a tibial insert, an acetabular liner, a glenoid liner, a patella, or an unicompartmental insert, to the counterface.
  • the term "mechanically interlocked” refers generally to interlocking of polyethylene and the counterface, that are produced by various methods, including compression molding, heat and irradiation, thereby forming an interlocking interface, resulting into a 'shape memory' of the interlocked polyethylene.
  • Components of a device having such an interlocking interface can be referred to as a "hybrid material”.
  • Medical implants having such a hybrid material contain a substantially sterile interface.
  • substantially sterile refers to a condition of an object, for example, • an interface or a hybrid material or a medical implant containing interface(s), wherein the interface is sufficiently sterile to not result in infection or require revision surgery.
  • Metallic mesh refers to a porous metallic surface of various pore sizes, for ' example, 0.1-3 mm.
  • the porous surface can be obtained through several different methods, for example, sintering of metallic powder with a binder that is subsequently removed to leave behind a porous surface; sintering of short metallic fibers of diameter 0.1-3 mm; or sintering of different size metallic meshes on top of each other to provide an open continuous pore structure.
  • “Bone cement” refers to what is known in the art as an adhesive used in bonding medical devices to bone. Typically, bone cement is made out of polymethylmetacrylate (PMMA).
  • High temperature compression molding refers to the compression molding of polyethylene in any form, for example, resin powder, flakes or particles, to impart new geometry under pressure and temperature. During the high temperature (above the melting point of polyethylene) compression molding, polyethylene is heated to above its melting point, pressurized into a mold of desired shape and allowed to cool down under pressure to maintain a desired shape.
  • Shape memory refers to what is known in the art as the property of polyethylene, for example, an UHMWPE, that attains a preferred low energy shape when melted.
  • the preferred low energy shape is achieved when the resin powder is consolidated through compression molding.
  • substantially no detectable residual free radicals refers to a state of a polyethylene component, wherein enough free radicals are eliminated to avoid oxidative degradation, which can be evaluated by electron spin resonance (ESR).
  • ESR electron spin resonance
  • the lowest level of free radicals detectable with state-of-the-art instruments is about 10 14 spins/gram and thus the term “detectable” refers to a detection limit of 10 14 spins/gram by ESR.
  • Ultra-high molecular weight polyethylene refers to linear non- branched chains of ethylene having molecular weights in excess of about 500,000, preferably above about 1 ,000,000, and more preferably above about 2,000,000.
  • the molecular weights can reach about 8,000,000 or more.
  • initial average molecular weight is meant the average molecular weight of the UHMWPE starting material, prior to any irradiation.
  • polymeric materials for example, a polyolefin, including high-density-polyethylene, low-density-polyethylene, linear-low-density-polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
  • polyolefin including high-density-polyethylene, low-density-polyethylene, linear-low-density-polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
  • UHMWPE ultra-high molecular weight polyethylene
  • the present invention relates to a method of sterilizing medical implants comprising a polymeric material, such as cross-linked UHMWPE, that is in contact with another piece, thereby forming an interface, comprising the steps of: a) sterilizing an interface by ionizing radiation; b) reducing free radicals in the UHMWPE under inert conditions; c) heating the medium to above the melting point of the irradiated UHMWPE (above about 137°C) to eliminate the crystalline matter and allow for the recombination/elimination of the residual free radicals and d) sterilizing the medical implant with a gas.
  • a polymeric material such as cross-linked UHMWPE
  • UHMWPE can be cross-linked by a variety of approaches, including those employing cross-linking chemicals (such as peroxides and/or silanes) and/or irradiation. Preferred approaches for cross-linking employ irradiation.
  • Crossed linked UHMWPE can be obtained according to the teachings of US Patent 5,879,400 and PCT/US97/02220. Interface:
  • interface in this invention is defined as the niche in medical devices formed when an implant is in a configuration where the UHMWPE is in contact with another piece (such as a metallic or a non-metallic component), which forms an interface between the polymer and the metal or another polymeric material.
  • another piece such as a metallic or a non-metallic component
  • interfaces of polymer-polymer or polymer-metal in medical prosthesis such as, orthopedic joints and bone replacement parts, e.g., hip, knee, elbow or ankle replacements.
  • the type of radiation preferably ionizing
  • a dose of ionizing radiation ranging from about 25 kGy to about 1000 kGy, preferably between about 50 kGy and about 100 kGy is used.
  • the radiation dose can be about 50 kGy, about 100 kGy, about 200 kGy, about 300 kGy, about 400 kGy, about 500 kGy, about 600 kGy, about 700 kGy, about 800 kGy, about 900 kGy, or about 1000 kGy, or any integer therebetween.
  • the irradiation may be carried-out in a sensitizing atmosphere.
  • a sensitizing atmosphere may comprise a gaseous substance which is of sufficiently small molecular size to diffuse into the polymer and which, on irradiation, acts as a polyfunctional grafting moiety.
  • gases include substituted or unsubstituted polyunsaturated hydrocarbons; for example, acetylenic hydrocarbons such as acetylene; conjugated or unconjugated olefinic hydrocarbons such as butadiene and (meth)acrylate monomers; sulphur monochloride, with chloro-tri- fluoroethylene (CTFE) or acetylene being particularly preferred.
  • CTFE chloro-tri- fluoroethylene
  • gaseous is meant herein that the sensitizing atmosphere is in the gas phase, either above or below its critical temperature, at the irradiation temperature.
  • the piece forming an interface with polymeric material is, for example, a metal.
  • the metal piece in functional relation with polyethylene, according to the present invention can be made of a cobalt chrome alloy, stainless steel, titanium, titanium alloy or nickel cobalt alloy, for example.
  • the piece forming an interface with polymeric material is, for example, a non-metal.
  • the non-metal piece in functional relation with polyethylene, according to the present invention can be made of ceramic material, for example.
  • inert atmosphere refers to an environment having no more than 1 % oxygen and more preferably, an oxidant-free condition that allows free radicals in polymeric materials to form cross links without oxidation during a process of sterilization.
  • An inert atmosphere is used to avoid O 2 , which would otherwise oxidize the medical device comprising a polymeric material, such as UHMWPE.
  • Inert atmospheric conditions such as nitrogen, argon, helium, neon, or vacuum are used for sterilizing polymeric medical implants by ionizing radiation.
  • Inert atmospheric conditions such as nitrogen, argon, helium, neon,- or vacuum are also used for sterilizing interfaces of polymeric-metallic and/or polymeric- polymeric in medical implants by ionizing radiation.
  • vacuum refers to an environment having no appreciable amount of gas that allows free radicals in polymeric materials to form cross links without oxidation during a process of sterilization.
  • An vacuum is used to avoid O 2 , which would otherwise oxidize the medical device comprising a polymeric material, such as UHMWPE.
  • a vacuum condition can be used for sterilizing polymeric medical implants by ionizing radiation.
  • a vacuum condition can be created using a commercially available vacuum pump.
  • a vacuum condition also can be used when sterilizing interfaces of polymeric- metallic and/or polymeric-polymeric in medical implants by ionizing radiation.
  • Residual free radicals refers to free radicals that are generated when a polymer is exposed to ionizing radiation such as gamma or e-beam irradiation. While some of the free radicals recombine with each other to from crosslinks, some become trapped in crystalline domains. The trapped free radicals are also known as residual free radicals.
  • the levels of residual free radicals in the polymer generated during an ionizing radiation is preferably determined using electron spin resonance and treated appropriately to reduce free radicals.
  • One aspect of the present invention discloses a process of reducing free radicals in polymeric component of a medical implant during the manufacturing process by heating for a time period depending on the melting temperature of the polymeric material.
  • the preferred temperature is about 137°C or more.
  • the invention discloses a heating step that is carried while the implant is in contact with an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
  • the invention discloses a heating step that is carried while the implant is in contact with a non-oxidizing medium, such as a fluid medium, wherein the medium contains no more than about 1% oxygen.
  • the invention discloses a heating step that is carried while the implant is in a vacuum.
  • the heating method of implants to reduce residual free radicals comprising a polymeric raw material, such as UHMWPE, is generally heated to a temperature of about 137°C or more.
  • the medical device is kept heated in the inert medium until the concentration of the residual free radicals is reduced to acceptable levels as measured by electron spin resonance. It is preferred that the concentration of the residual free radicals is at or below the detection limit of electron spin resonance. Soaking Process:
  • the present invention also provides conditions of treatment of reducing residual free radicals by soaking the implant in a sensitizing atmosphere such as immersing the implant into acetylene or another sensitizmg gas which can be pressured into the implant.
  • a sensitizing atmosphere such as immersing the implant into acetylene or another sensitizmg gas which can be pressured into the implant.
  • the sensitizing gas diffuses in and reacts with residual free radicals forming additional cross-links.
  • the invention further relates to a process, if necessary, to accelerate the diffusion of the sensitizing gas by increasing temperature of the chamber that holds the implant and the gas.
  • contacted in this context includes close physical proximity with or touching such that the sensitizing agent can perform its intended function.
  • a polyethylene composition or pre-form is sufficiently contacted such that it is soaked in the sensitizing agent, which ensures that the contact is sufficient.
  • Soaking is defined as placing the sample in a specific environment for a sufficient period of time at an appropriate temperature.
  • the environment include a sensitizing gas, such as acetylene, ethylene, or a similar gas or mixture of gases, or a sensitizing liquid, for example, a diene.
  • the environment is heated to a temperature ranging from room temperature to a temperature above the melting point of the polymeric material.
  • the contact period ranges from at least about 1 minute to several weeks and the duration depending on the temperature of the environment. In one aspect, the contact time period at room temperature is about 24 hours to about 48 hours and preferably about 24 hours.
  • a “sensitizing environment” refers to a mixture of gases and/or liquids (at room temperature) that contain sensitizing gaseous and/or liquid component(s) that can react with residual free radicals to assist in the recombination and elimination of the residual free radicals.
  • the gases may be acetylene, chloro-trifluoro ethylene (CTFE), ethylene, or like.
  • CTFE chloro-trifluoro ethylene
  • the gases or the mixtures of gases thereof may contain noble gases such as nitrogen, argon, neon and like. Other gases such as, carbon dioxide or carbon monoxide may also be present in the mixture.
  • the gas blend could also contain oxidizing gases such as oxygen.
  • the sensitizing environment can be dienes with different number of carbons, or mixtures of liquids and/or gases thereof.
  • An example of a sensitizing liquid component is octadiene or other dienes, which can be mixed with other sensitizing liquids and/or non-sensitizing liquids such as a hexane or a heptane.
  • a sensitizing environment can include a sensitizing gas, such as acetylene, ethylene, or a similar gas or mixture of gases, or a sensitizing liquid, for example, a diene. The environment is heated to a temperature ranging from room temperature to a temperature above the melting-point of the polymeric material.
  • Example 1 Compression molding, mechanical interlocks in medical devices, and irradiation of hybrid components:
  • Figure 1 diagrams sequential steps in compression molding of polyethylene powder to a metallic mesh.
  • Step-1 shows a mesh-like surface (20) on the other side facing the polyethylene powder (10) is compression molded.
  • Step-2 shows the consolidated polyethylene (15) taking a shape at the interface that penetrates into the mesh and Step-3 depicting consolidated polyethylene partially penetrating the metallic mesh and forming a hybrid component (30) with an interlocking interface.
  • the mesh surface on the other side is continuous through the interface or intermittent.
  • the hybrid component is irradiated, melted and then machined for final shape.
  • Polyethylene resin powder was placed on top of a metallic mesh as shown in
  • Figure 2 shows an example of a compression molded polyethylene (60) to a metallic back (40) containing metallic mesh (20) and a metallic backed Patella (70).
  • Figure 3 shows an example of a compression molded of polyethylene (120) to a metal shell (100) containing metallic mesh (20).
  • Figures 4 and 5 show examples of metal trays (40) containing metallic mesh (20) and undercuts or recess (80), respectively, to secure compression molded polyethylene.
  • Figures 4 and 5 or the like that allowed the polyethylene resin powder to penetrate, consolidate and take the shape of the surface such that the mechanical interlocking is achieved and resulted into a hybrid component (30) having strong interlocking interface (see Figure 1).
  • polyethylene resin powder was consolidated to a mesh surface that has a solid metal backing for the manufacture of a patellar implant.
  • the consolidated group was irradiated to crosslink the polyethylene and to sterilize the polyethylene/metallic mesh interface.
  • the implant was melted to reduce the concentration of residual free radicals.
  • the articulating surface of the implant was then machined to the desired geometry. Finally the implant was sterilized using a gas (ethylene oxide, gas plasma, or the other gas).
  • Figure 3 shows the same as in Figure 2, however, polyethylene resin powder was consolidated to a mesh surface in a different geometry.
  • Figures 4 and 5 depict two alternative counterface interlocking geometries.
  • Figure 4 shows an intermittent metallic mesh on a solid metallic back, wherein the mesh acts as the interlocking counterface.
  • the intermittent mesh on a solid metal backing can be used in a variety of geometries such as a tibial knee insert, bipolar acetabular component, acetabular component, patellar components, or shoulder glenoid.
  • Figure 5 shows an undercut geometry into which polyethylene provides interfacial strength between the polyethylene and the metallic back. The shape and dimensions of the undercut can be varied to improve the interface strength.
  • This type of interface geometry can be used in a variety of flat, concave, or convex interface geometries in a variety of implants.
  • the consolidated polyethylene can penetrate the full thickness of the metallic mesh. However, sufficient interface strength can be achieved even with partial penetration.
  • Figure 2 depicts a combination of interface surfaces, for example, a mesh (20) and a macro-geometries is combined to tailor an interface of preferred strength.
  • Figure 3 shows a polyethylene (120), which is direct compression molded to a metallic mesh counterface (20) and/or a metal back metal shell (100) with a mechanical interlock, thereby forming a hybrid component.
  • the hybrid component was irradiated using ionizing radiation to a desired dose level, for example, about 25 kGy to about 1000 kGy, preferably between about 50 kGy and about 100 kGy. Irradiation crosslinked the polymer, as well as sterilized the interface that is in close contact between the polyethylene and counterface.
  • *' residual free radicals were generated, which may compromise the long-term oxidative stability of the polymer and in vivo device performance. Therefore, a melting step at this point in the fabrication is used to quench the residual free radicals. Because the resin powder was consolidated into the shape of the interface, which sets the shape memory of the polymer, the polyethylene did not separate from the counterface.
  • Example 2 Melting of interlocked interface in a non-oxidizing medium: A medical device, for example, manufactured following a process as described in the examples 1 or 2, was immersed in a non-oxidizing medium such as inert gas or inert fluid. The medium was heated to above the melting point of the irradiated UHMWPE (about >137°C) to eliminate the crystalline matter and allowed for the recombination/elimination of the residual free radicals. Because the shape memory of the compression molded polymer is set at the mechanically interlocked interface and that memory is strengthened by the crosslinking step, there was no significant separation at the interface between the polyethylene and the counterface.
  • a non-oxidizing medium such as inert gas or inert fluid.
  • the medium was heated to above the melting point of the irradiated UHMWPE (about >137°C) to eliminate the crystalline matter and allowed for the recombination/elimination of the residual free radicals. Because the shape memory of the compression molded polymer is set at
  • the implant is sterilized with ethylene oxide, gas plasma, or the other gas.
  • Example 4 Preparation of a polyethylene/mesh assembly by high temperature compression of a consolidated polyethylene cylinder to a metallic mesh:
  • Example 5 Compression molding of polyethylene resin powder to a metallic mesh:
  • a SS304 woven wire mesh (Southwestern Wire Cloth, Tulsa, OK) with 60 mesh per inch, 0.0075" wire diameter, 0.0092" opening width, and 30.5% open area was used along with GUR 1050 ultra-high molecular weight virgin resin (Perplas Ltd., Bacup, UK) flakes were used in the consolidation experiments.
  • Example 6 Fabrication of a crosslinked UHMWPE incorporated into a metal-mesh backing with a sterile interface:
  • the shape memory of the UHMWPE was set to a geometry that included the mesh unlike what was observed in Example 4, where the shape memory recovery of the original dimensions of the pin led to the dissociation of the mesh.
  • Figures 9-10 show examples of the retention of the mesh following post- irradiation melting.
  • the polyethylene resin needs to be consolidated to a original shape memory that also includes the metallic structure of interest to avoid dissociation following post-irradiation melting.

Abstract

The present invention relates to medical implants that comprise crosslinked polyethylene (UHMWPE) (10) that is pressed into a consolidated form (15) in contact with another piece (such as a metallic mesh or back, a non-metallic mesh or back, a tibial tray, a patella tray, or an acetabular shell) (20) thereby forming an interface, and a hybrid component (30). Also disclosed herein are the methods of manufacturing and sterilizing such medical devices and materials used therein.

Description

Inventors: Orhun K. Muratoglu William H. Harris
METAL BACK OR MESH CROSSLINKING
This application claims priority to U. S. Serial No. 60/390,120, filed June 21, 2002, and U. S. Serial No. 60/424,709, filed November 08, 2002, the entireties of which are hereby incorporated by reference.
Field of the Invention
The present invention relates to a medical implant that comprises polymeric material that is in contact (which includes close proximity and touching) with another piece (such as a metallic mesh or back, a non-metallic mesh or back, a tibial tray, a patella tray, or an acetabular shell), thereby forming an interface. Methods of manufacturing and sterilizing such devices and materials used therein also are provided.
Background of the Invention
Increased crosslink density in polyethylene is desired in bearing surface applications for joint arthroplasty because it significantly increases the wear resistance of this material. The preferred method of crosslinking is by exposing the polyethylene to ionizing radiation. However, ionizing radiation, in addition to crosslinking, also will generate residual free radicals, which are the precursors of oxidation-induced embrittlement. This is known to adversely affect in vivo device performance. Therefore, it is desirable to reduce the concentration of residual free radicals, preferably to undetectable levels, following irradiation so as to avoid long-term oxidation.
Methods of irradiating polymers are described in U.S. Patent No. 5,897,400. In general, this patent describes medical prosthesis formed, at least in part, of a melt- irradiated crosslinked high molecular weight polyethylene. The disclosed melt- irradiation process improves the wear resistance of the polymer, thus addressing the problem of severe adverse effects associated with the use of less wear resistant polymers. U.S. Patent No. 5,897,400 describes, among other things, heating the polymers to or above the melting point, irradiating the polymer, and cooling the polymer.
International Application No. PCT US97/02220 (WO 97/29793) also describes the irradiation of polymers that are useful in the orthopedic field. In this application, several methods of increasing the wear characteristics of polymers are described. The application describes, among other things, an irradiation procedure wherein the polymer is irradiated at room temperature or below. Following irradiation, the polymer can be heated to or above the melting temperature to remove any residual free radicals through the process of recombination. The application also describes another irradiation method in which the polymer is pre-heated to a temperature above room temperature, but below the melting temperature, and irradiated. Following irradiation, the polymer may be subsequently melted by heating it to the melting temperature or above to substantially eliminate any detectable free radicals via the process of recombination.
WO 97/29793 also describes methods of irradiating polymers in which the heat generated by the irradiation is sufficient to at least partially melt the polymer, and is described as "adiabatic" melting or heating. Adiabatic melting or heating refers to heating induced by radiation, which leads to an increase of the temperature of the polymer with substantially little loss of heat to the surroundings. The application describes an adiabatic melting method, among other things, in which the polymer is preheated to a temperature below the melting point, then irradiated with enough total dose and at a high enough dose rate to at least partially melt the polymer crystals. Subsequent to this warm-irradiation, the polymer also can be heated to or above the melting temperature such that any residual free radicals are eliminated. The application also describes another irradiation, adiabatic melting method that is similar to the method described above, except that the polymer is provided at room temperature or below.
It is important that crosslinked ultra-high molecular weight polyethylene (UHMWPE) based medical devices are sterilized after they are packaged for in vivo use. There are several methods of sterilization that can be utilized for medical implants, such as the use of ethylene oxide, gas plasma, heat (autoclave), or radiation. However, applying heat to a packaged polymeric medical product can destroy either the integrity of the packaging material (particularly the seal, which is provided to prevent bacteria and other contaminants from entering the package after the sterilization step) or the product itself. Because ethylene oxide may adversely impact environmental and employee safety, gamma ray, x-ray or electron beam radiation has been utilized as a preferred means of sterilization. These types of radiation use a high- energy beam to destroy or inactivate bacteria, viruses, and other microbial species that contaminate the packaged medical products.
However, it has been recognized that regardless of the radiation type, the high- energy beam causes generation of free radicals in polymers during irradiation. It also has been recognized that the amount of free radicals generated is dependent upon the radiation dose received by the polymers and that the distribution of free radicals in the polymeric implant depends upon the geometry of the component, the type of polymer, the dose rate, and the type of radiation.
Currently available methods of sterilization of medical devices containing polymeric materials include use of ethylene oxide (EtO) or gas plasma (GP). Although EtO and GP are successfully used in sterilizing certain polymeric implants, despite environmental and safety concerns, there are some implant designs where these gas sterilization methods will not work. These medical implants often contain factory-assembled pieces (usually a metallic or ceramic component) that are in close contact with the UHMWPE. In most cases, the interface is not accessible to the EtO gas or the GP. Therefore, these implants must be sterilized by gamma radiation, in air or in inert atmospheres. Yet these methods generate enough residual free radicals to adversely affect device performance in the long-term. With the recent introduction of radiation and thermal treatment of UHMWPE to improve its wear behavior and its long-term stability, gamma sterilization is no longer favored. In view of the limitations of the commercialized processes, new approaches are needed that will provide an alternative method of manufacturing crosslinked polymeric material (for example, UHMWPE)-based medical implants in configurations wherein the polymeric component is in close contact with another piece (such as another component, for example, a metallic or a non-metallic component).
The current invention, therefore, provides improved methods of making and sterilizing medical implants that contains highly cross-linked polymeric material, wherein the polymeric component (for example, UHMWPE) is in close contact with another piece (such as another component, for example, a metallic or a non-metallic component).
Summary of the Invention
The present invention relates generally to methods of manufacturing and sterilizing medical implants comprising a polymeric material, such as cross-linked ultra-high molecular weight polyethylene (UHMWPE), that is in contact with another piece (generally a metallic piece), thereby forming an interface, for example, an interlocking interface.
In one aspect, the invention provides methods of making a medical implant containing crosslinked polyethylene, for example, ultra-high molecular weight polyethylene (UHMWPE) that is in contact with another piece, thereby forming an interface, comprising the steps of: a) compression molding of polyethylene, including powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the crosslinked polyethylene by heating the hybrid material above the melting point of the crosslinked polyethylene. Polyethylene sheets also can be employed, but they may not result in the attainment of interlocking interfaces.
The metallic or non-metallic back or mesh as described, in one aspect of the invention, is shaped to serve as a fixation interface with the bone, through either bony growth or by bone cement, wherein the shapes are in the form of acetabular liner, tibial tray for total or unicompartmental knee implants, patella tray, glenoid component, ankle, elbow or finger component.
In another aspect, the invention includes methods of making a medical implant containing crosslinked polyethylene, for example, UHMWPE, that is in contact with another piece, thereby forming an interface, wherein the polyethylene, including powder, flakes and particles are compression molded to a metallic mesh, wherein the metallic mesh is shaped to serve as a fixation interface with the bone, through either bony growth or by bone cement, wherein the shapes are, for example, in the form of acetabular liner, tibial tray for total or unicompartmental knee implants, patella tray, glenoid component, ankle, elbow or finger component.
The polyethylene, as described herein, is in contact with another piece, thereby forming an interface, for example, an interlocking interface, wherein the interface is rendered substantially sterile.
In another aspect, the invention provides methods of making medical devices including bipolar hip replacements, tibial knee inserts with reinforcing metallic and polyethylene posts, and an implant that contains an interface that cannot be sterilized by a gas sterilization method.
In another aspect, the invention provides medical implants manufactured by the methods described herein. In another aspect, the invention provides methods of: sterilizing a medical implant containing crosslinked polyethylene that is in contact with another piece, thereby forming an interface, wherein the methods comprise the steps of a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; c) reducing free radicals in the crosslinked polyethylene by heating the hybrid material above the melting point of the crosslinked polyethylene; and d) sterilizing the medical implant with a gas.
Another aspect of the present invention includes methods of sterilization, wherein the implants are further sterilized by a gas, wherein the gas is ethylene oxide, gas plasma, or the other gas, wherein ethylene oxide, gas plasma, or the other gas, is used for gas sterilization.
In another aspect, the invention provides medical implants, comprising crosslinked polyethylene that is in contact with another piece, thereby forming an interface, made by processes comprising the steps of: a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the crosslinked polyethylene by heating the hybrid material above the melting point of the crosslinked polyethylene.
In another aspect, the invention provides medical implants, comprising crosslinked polyethylene that is in contact with another piece, thereby forming an interface, made by processes comprising the steps of: a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the crosslinked polyethylene by heating the hybrid material above the melting point of the crosslinked polyethylene. In another aspect, the invention provides interfaces made by processes comprising the steps of: a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the polyethylene by heating the hybrid material above the melting point of the polyethylene.
In another aspect, the invention provides interfaces made by processes comprising the steps of: a) compression molding of polyethylene to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the polyethylene by heating the hybrid material above the melting point of the polyethylene.
In another aspect; the invention provides interfaces made by processes comprising the steps of: a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; and b) irradiating the hybrid material by ionizing radiation, wherein the interface is rendered substantially sterile.
In another aspect, the invention provides interfaces made by processes comprising the steps of: a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming a mechanically interlocked hybrid material; and b) irradiating the hybrid material by ionizing radiation, wherein the interface is rendered substantially sterile.
In another aspect, the invention provides interfaces made by processes comprising the steps of: a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the polyethylene by heating the hybrid material above the melting point of the polyethylene, wherein the interface is rendered substantially sterile. In another aspect, the invention provides interfaces made by processes comprising the steps of: a) compression molding of polyethylene, such as resin powder, flakes and particles to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the polyethylene by heating the hybrid material above the melting point of the polyethylene, wherein the interface is rendered substantially sterile.
In another aspect, the invention provides acetabular assemblies comprising: a) polyethylene powder compression molded to another piece, thereby forming an interlocked hybrid material; b) a substantially sterile interface; and c) a metallic back.
In another aspect, the invention provides acetabular assemblies comprising: a) a polyethylene acetabular liner compression molded to another piece, thereby forming a mechanically interlocked hybrid material; b) a substantially sterile interface; and c) a metallic back.
Another aspect of the invention provides medical implants comprising crosslinked polyethylene having substantially no detectable free radicals; and at least one substantially sterile interface, for example, a substantially sterile mechanically interlocking interface.
Another aspect of the invention provides medical implants comprising crosslinked polyethylene having substantially no detectable free radicals; and a sterile mechanically interlocking interface, wherein polyethylene, such as resin powder, flakes and particles are compression molded to another piece, for example, a metallic mesh or back, a non-metallic mesh or back such as ceramic mesh or back, a tibial tray, a patella tray, or an acetabular shell.
The heating temperature of the compressed polyethylene or the hybrid components are above the melting point of the polyethylene, preferably above about 137°C and the radiation dose at the melt is between about 25 kGy and about 1000 kGy. The radiation dose can be about 50 kGy, about 100 kGy, about 200 kGy, about 300 kGy, about 400 kGy, about 500 kGy, about 600 kGy, about 700 kGy, about 800 kGy, about 900 kGy, or about 1000 kGy.
In one aspect of the invention, the heating of the hybrid material above the melting point of the polyethylene is carried out in air, wherein the air contains between about 1% and about 22% oxygen. In a preferred aspect of the invention, the heating is carried out in air containing between about 2% and about 21% oxygen.
In another aspect, the heating of the hybrid material above the melting point of the polyethylene is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
In another aspect, the heating of the hybrid material above the melting point of the polyethylene is carried out in a vacuum.
The counterface piece as described, in one aspect of the invention, comprises a metal or a non-metal, wherein the piece is a metallic mesh or back, a ceramic mesh or back, a tibial tray, a patella tray, or an acetabular shell, wherein the piece comprises a metallic mesh or back, a non-metallic mesh or back, an undercut, a recess or a combination thereof.
The interfaces as described in one aspect of the invention, comprise a metal- polymer, wherein the polymer is a polyolefin, wherein the polyolefin is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
In another aspect, the invention provides methods of sterilization, wherein the implant comprises medical devices selected from the group consisting of bipolar hip replacements, tibial knee inserts with reinforcing metallic and polyethylene posts, and an implant that contains an interface that cannot be readily sterilized by a gas sterilization method.
In one aspect of the invention, the ionizing radiation includes gamma or ionizing irradiation in air, wherein the air contains between about 1% and about 22% oxygen. In a preferred aspect of the invention, the radiation is carried out in air containing between about 2% and about 21% oxygen. In another aspect, the ionizing radiation includes gamma or ionizing irradiation in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof. In another aspect, the ionizing radiation includes gamma or ionizing irradiation in a vacuum.
Following irradiation, the reduction of free radicals in the crosslinked polyethylene is achieved by heating the implants to above the melting temperature of the polyethylene, wherein the polyethylene can be in contact with a non-oxidizing medium, wherein the non-oxidizing medium is an inert gas or an inert fluid, wherein the medium is a polyunsaturated hydrocarbon selected from the group consisting of: acetylenic hydrocarbons such as acetylene; conjugated or unconjugated olefinic hydrocarbons such as butadiene and (meth)acrylate monomers; and sulphur monochloride with chloro-tri-fluoroethylene (CTFE) or acetylene. In one aspect of the invention, the reduction of free radicals in crosslinked polyethylene is achieved in air, wherein the air contains between about 1 % and about 22% oxygen. I a preferred aspect of the invention, the radiation is carried out in air containing between about 2% and about 21% oxygen.
In another aspect, the reduction of free radicals in crosslinked polyethylene is achieved in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
In another aspect, the reduction of free radicals in crosslinked polyethylene is achieved in a vacuum. In one aspect, the invention provides medical implants comprising crosslinked polyethylene having substantially no detectable free radicals; and a sterile interface such as a mechanically interlocking interface. The polyethylene of the implant as described herein is in contact with another piece, thereby forming an interface, wherein the polyethylene, such as resin powder, flakes and particles are compression molded to another piece, for example, a metal or a non-metal, thereby forming a mechanically interlocked hybrid material. The implant as described herein is compression molded, wherein polyethylene, such as resin powder, flakes and particles are compression molded to another piece, for example, a metallic mesh or back, or a non-metallic mesh or back such as a ceramic mesh or back, a tibial tray, a patella tray, or an acetabular shell. The implant as described herein comprises a metal-polymer interface, wherein the metal piece comprises a metallic mesh or back, or a non-metallic mesh or back such as a ceramic mesh or back, an undercut, a recess or a combination thereof, thereby forming a mechanically interlocked hybrid material.
Brief Description of the Drawings Figures 1 shows sequential steps in compression molding of polyethylene powder (10) to a metallic mesh (20).
Figure 2 illustrates compression molding of polyethylene (60) on a metallic back (40) containing a metallic mesh (20) and a metallic backed Patella (70).
Figure 3 shows compression molding of polyethylene (120) on a metal shell (100) containing metallic mesh (20).
Figure 4 shows metallic tray (40) having mesh (20).
Figure 5 shows metallic tray (40) having undercut (80).
Figure 6 shows a schematic diagram of compression apparatus set up.
Figure 7 depicts a typical mesh incorporated into UHMWPE pin by high temperature compression.
Figure 8 illustrates a mesh incorporated into polyethylene by compression molding polyethylene resin powder.
Figure 9 depicts an example of mesh retention in the polyethylene resin/mesh assembly following irradiation and subsequent melting, that is post-irradiation before melting.
Figure 10 depicts an example of mesh retention in the polyethylene resin/mesh assembly following irradiation and subsequent melting, that is post-irradiation after melting. Detailed Description of the Invention
The present invention relates generally to methods of manufacturing and sterilizing medical implants comprising a polymeric material, such as cross-linked ultra-high molecular weight polyethylene (UHMWPE), that is in contact with another piece (for example, a metallic or non-metallic component), thereby forming an interlocking interface.
One aspect of the invention relates to the following processing steps to fabricate medical devices made out of highly crosslinked UHMWPE and containing metallic pieces such as bipolar hip replacements, tibial knee inserts with reinforcing metallic and polyethylene posts, and for any implant that contains a surface that cannot be readily sterilized by a gas sterilization method.
According to one aspect of the invention, the UHMWPE component of a medical implant is in close contact with another material (such as a metallic mesh or back, a non-metallic mesh or back, a tibial tray, a patella tray, or an acetabular shell), wherein polyethylene, such as resin powder, flakes and particles are directly compression molded to these counterfaces. For example, a polyethylene tibial insert is manufactured by direct compression molding of polyethylene resin powder to a tibial tray, to a metallic mesh or back or to a non-metallic mesh or back. In the latter case, the mesh is shaped to serve as a fixation interface with the bone, through either bony in-growth or the use of an adhesive, such as PMMA bone cement. These shapes are of various forms including, acetabular liner, tibial tray for total or unicompartmental knee implants, patella tray, and glenoid component, ankle, elbow or finger component. One aspect of the invention relates to mechanical interlocking of the molded polyethylene with the other piece(s), for example, a metallic or a non- metallic piece, that makes up part of the implant.
Another aspect of the invention provides methods for achieving mechanically interlocked medical devices. For example, a mesh-like surface on the other side facing the polyethylene powder is compression molded and the consolidated polyethylene takes a shape at the interface that penetrates into the mesh. The mesh surface on the other side can be continuous through the interface or intermittent (see Figure 1). Another aspect of the invention includes surfaces with geometries, for example, undercuts, grooves (see Figures 4-5), or the like that allows the polyethylene, such as resin powder, flakes and particles to penetrate, consolidate and . take the shape of the surface such that the mechanical interlocking achieved allows for a strong interface (see Figure 4).
Another aspect of the invention provides combination of interface surfaces, for example, a mesh and macro-geometries are combined to tailor an interface of preferred strength (see Figure 2).
The interface geometry is crucial in that polyethylene assumes the geometry as its consolidated shape. UHMWPE has a remarkable property of 'shape memory' due to its very high molecular weight that results in a high density of physical entanglements. Following consolidation, plastic deformation introduces a permanent shape change, which is almost completely reversed by melting. This recovery of the original consolidated shape is due to the 'shape memory', which is triggered by melting.
Another aspect of the invention provides that following the direct compression moldings of the polyethylene to the counterface with the mechanical interlock, the hybrid component is irradiated using ionizing radiation to a desired dose level, for example, about 25 kGy to about 1000 kGy, preferably between about 50 kGy and about 100 kGy. In accordance with aspects of the invention, the invention discloses that while the irradiation crosslinks the polymer, it also sterilizes the interfaces, that is the close contact between the polyethylene and the counterface. Another aspect of the invention discloses that the irradiation step generates residual free radicals and therefore, a melting step is introduced thereafter to quench the residual free radicals. Since the polyethylene is consolidated into the shape of the interface, thereby setting a 'shape memory' of the polymer, the polyethylene does not separate from the counterface.
In another aspect of the invention, there are provided methods of crosslinking polyethylene, to create a UHMWPE-based medical device, wherein the device is immersed in a non-oxidizing medium such as inert gas or inert fluid, wherein the medium is heated to above the melting point of the irradiated polyethylene, for example, UHMWPE (above about 137°C) to eliminate the crystalline matter and to allow the recombination/elimination of the residual free radicals. Because the shape memory of the compression molded polymer is set at the mechanically interlocked interface and that memory is strengthened by the crosslinking step, there is no significant separation at the interface between the polyethylene and the counterface. Another aspect of the invention provides that following the above steps of free radical elimination, the interface between the metal and the polymer become sterile due to the high irradiation dose level used during irradiation. When there is substantial oxidation on the outside surface of the polyethylene induced during the free radical elimination step or irradiation step, the device surface can be further machined to remove the oxidized surface layer. In another aspect, the invention provides that in the case of a post-melting machining of an implant, the melting step is carried out in the presence of an inert gas.
Another aspect of the invention includes methods of sterilization of the fabricated device, wherein the device is further sterilized with ethylene oxide, gas plasma, or the other gases, when the interface is sterile but the rest of the component is not.
The term "compression molding" as referred herein related generally to what is known in the art and specifically relates to molding applicable in polyethylene-based devices, for example, medical implants wherein polyethylene in any physical state, including powder form, is compressed to solid support, for example, a metallic back, metallic mesh, or metal surface containing grooves, undercuts, or cutouts. The compression molding also includes high temperature compression molding of polyethylene at various states, including resin powder, flakes and particles, to make a component of a medical implant, for example, a tibial insert, an acetabular liner, a glenoid liner, a patella, or an unicompartmental insert, to the counterface.
The term "mechanically interlocked" refers generally to interlocking of polyethylene and the counterface, that are produced by various methods, including compression molding, heat and irradiation, thereby forming an interlocking interface, resulting into a 'shape memory' of the interlocked polyethylene. Components of a device having such an interlocking interface can be referred to as a "hybrid material". Medical implants having such a hybrid material, contain a substantially sterile interface. The term "substantially sterile" refers to a condition of an object, for example, an interface or a hybrid material or a medical implant containing interface(s), wherein the interface is sufficiently sterile to not result in infection or require revision surgery. "Metallic mesh" refers to a porous metallic surface of various pore sizes, for ' example, 0.1-3 mm. The porous surface can be obtained through several different methods, for example, sintering of metallic powder with a binder that is subsequently removed to leave behind a porous surface; sintering of short metallic fibers of diameter 0.1-3 mm; or sintering of different size metallic meshes on top of each other to provide an open continuous pore structure. "Bone cement" refers to what is known in the art as an adhesive used in bonding medical devices to bone. Typically, bone cement is made out of polymethylmetacrylate (PMMA).
"High temperature compression molding" refers to the compression molding of polyethylene in any form, for example, resin powder, flakes or particles, to impart new geometry under pressure and temperature. During the high temperature (above the melting point of polyethylene) compression molding, polyethylene is heated to above its melting point, pressurized into a mold of desired shape and allowed to cool down under pressure to maintain a desired shape.
"Shape memory" refers to what is known in the art as the property of polyethylene, for example, an UHMWPE, that attains a preferred low energy shape when melted. The preferred low energy shape is achieved when the resin powder is consolidated through compression molding.
The phrase "substantially no detectable residual free radicals" refers to a state of a polyethylene component, wherein enough free radicals are eliminated to avoid oxidative degradation, which can be evaluated by electron spin resonance (ESR). The lowest level of free radicals detectable with state-of-the-art instruments is about 1014 spins/gram and thus the term "detectable" refers to a detection limit of 1014 spins/gram by ESR.
The terms "about" or "approximately" in the context of numerical values and ranges refers to values or ranges that approximate or are close to the recited values or ranges such that the invention can perform as intended, such as having a desired degree of crosslinking and/or a desired lack of free radicals, as is apparent to the skilled person from the teachings contained herein. This is due, at least in part, to the varying properties of polymer compositions. Thus these terms encompass values beyond those resulting from systematic error. Polymeric Material: Ultra-high molecular weight polyethylene (UHMWPE) refers to linear non- branched chains of ethylene having molecular weights in excess of about 500,000, preferably above about 1 ,000,000, and more preferably above about 2,000,000. Often the molecular weights can reach about 8,000,000 or more. By initial average molecular weight is meant the average molecular weight of the UHMWPE starting material, prior to any irradiation. See US Patent 5,879,400, PCT/US99/16070, filed on July 16, 1999, and PCT/US 97/02220, filed February 11, 1997, the entirety of which are hereby incorporated by reference.
The products and processes of this invention also apply to various types of polymeric materials, for example, a polyolefin, including high-density-polyethylene, low-density-polyethylene, linear-low-density-polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof. Polymeric materials, as used herein, also applies to polyethylene of various forms, for example, resin powder, flakes and particles.
Sterilization Steps: The present invention relates to a method of sterilizing medical implants comprising a polymeric material, such as cross-linked UHMWPE, that is in contact with another piece, thereby forming an interface, comprising the steps of: a) sterilizing an interface by ionizing radiation; b) reducing free radicals in the UHMWPE under inert conditions; c) heating the medium to above the melting point of the irradiated UHMWPE (above about 137°C) to eliminate the crystalline matter and allow for the recombination/elimination of the residual free radicals and d) sterilizing the medical implant with a gas.
UHMWPE can be cross-linked by a variety of approaches, including those employing cross-linking chemicals (such as peroxides and/or silanes) and/or irradiation. Preferred approaches for cross-linking employ irradiation. Crossed linked UHMWPE can be obtained according to the teachings of US Patent 5,879,400 and PCT/US97/02220. Interface:
The term interface in this invention is defined as the niche in medical devices formed when an implant is in a configuration where the UHMWPE is in contact with another piece (such as a metallic or a non-metallic component), which forms an interface between the polymer and the metal or another polymeric material. For example, interfaces of polymer-polymer or polymer-metal in medical prosthesis such as, orthopedic joints and bone replacement parts, e.g., hip, knee, elbow or ankle replacements.
Medical implants containing factory-assembled pieces that are in close contact with the UHMWPE form interfaces. In most cases, the interfaces are not readily accessible to EtO gas or the GP during a gas sterilization process. Irradiation:
In one aspect of the invention, the type of radiation, preferably ionizing, is used. According to another aspect of the invention, a dose of ionizing radiation ranging from about 25 kGy to about 1000 kGy, preferably between about 50 kGy and about 100 kGy is used. The radiation dose can be about 50 kGy, about 100 kGy, about 200 kGy, about 300 kGy, about 400 kGy, about 500 kGy, about 600 kGy, about 700 kGy, about 800 kGy, about 900 kGy, or about 1000 kGy, or any integer therebetween. These types of radiation, including gamma and/or electron beam, kills or inactivates bacteria, viruses, or other microbial agents potentially contaminating medical implants, including the interfaces, thereby achieving product sterility. The irradiation, which may be electron or gamma irradiation, in accordance with the present invention is carried out in air atmosphere containing oxygen, wherein the oxygen concentration in the atmosphere is at least 1%, 2%, 4%, or up to about 22%, or any integer thereabout or therebetween. In another aspect, the irradiation is carried out in an inert atmosphere, wherein the atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof. The irradiation also can be carried out in a vacuum.
In accordance with a preferred feature of this invention, the irradiation may be carried-out in a sensitizing atmosphere. This may comprise a gaseous substance which is of sufficiently small molecular size to diffuse into the polymer and which, on irradiation, acts as a polyfunctional grafting moiety. Examples include substituted or unsubstituted polyunsaturated hydrocarbons; for example, acetylenic hydrocarbons such as acetylene; conjugated or unconjugated olefinic hydrocarbons such as butadiene and (meth)acrylate monomers; sulphur monochloride, with chloro-tri- fluoroethylene (CTFE) or acetylene being particularly preferred. By "gaseous" is meant herein that the sensitizing atmosphere is in the gas phase, either above or below its critical temperature, at the irradiation temperature.
Metal Piece:
In accordance with the invention, the piece forming an interface with polymeric material is, for example, a metal. The metal piece in functional relation with polyethylene, according to the present invention, can be made of a cobalt chrome alloy, stainless steel, titanium, titanium alloy or nickel cobalt alloy, for example.
Non-metallic Piece:
In accordance with the invention, the piece forming an interface with polymeric material is, for example, a non-metal. The non-metal piece in functional relation with polyethylene, according to the present invention, can be made of ceramic material, for example.
Inert Atmosphere:
The term "inert atmosphere" refers to an environment having no more than 1 % oxygen and more preferably, an oxidant-free condition that allows free radicals in polymeric materials to form cross links without oxidation during a process of sterilization. An inert atmosphere is used to avoid O2, which would otherwise oxidize the medical device comprising a polymeric material, such as UHMWPE. Inert atmospheric conditions such as nitrogen, argon, helium, neon, or vacuum are used for sterilizing polymeric medical implants by ionizing radiation. Inert atmospheric conditions such as nitrogen, argon, helium, neon,- or vacuum are also used for sterilizing interfaces of polymeric-metallic and/or polymeric- polymeric in medical implants by ionizing radiation.
Vacuum:
The term "vacuum" refers to an environment having no appreciable amount of gas that allows free radicals in polymeric materials to form cross links without oxidation during a process of sterilization. An vacuum is used to avoid O2, which would otherwise oxidize the medical device comprising a polymeric material, such as UHMWPE. A vacuum condition can be used for sterilizing polymeric medical implants by ionizing radiation.
A vacuum condition can be created using a commercially available vacuum pump. A vacuum condition also can be used when sterilizing interfaces of polymeric- metallic and/or polymeric-polymeric in medical implants by ionizing radiation.
Residual Free Radicals:
"Residual free radicals" refers to free radicals that are generated when a polymer is exposed to ionizing radiation such as gamma or e-beam irradiation. While some of the free radicals recombine with each other to from crosslinks, some become trapped in crystalline domains. The trapped free radicals are also known as residual free radicals.
According to one aspect of the invention, the levels of residual free radicals in the polymer generated during an ionizing radiation (such as gamma or electron beam) is preferably determined using electron spin resonance and treated appropriately to reduce free radicals.
Heating Process:
One aspect of the present invention discloses a process of reducing free radicals in polymeric component of a medical implant during the manufacturing process by heating for a time period depending on the melting temperature of the polymeric material. For example, the preferred temperature is about 137°C or more.
Another aspect of the invention discloses a heating step that is carried in the air, in an atmosphere, containing oxygen, wherein the oxygen concentration is at least 1%, 2%,
4%, or up to about 22%, or any integer thereabout or therebetween. In another aspect, the invention discloses a heating step that is carried while the implant is in contact with an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof. In another aspect, the invention discloses a heating step that is carried while the implant is in contact with a non-oxidizing medium, such as a fluid medium, wherein the medium contains no more than about 1% oxygen. In another aspect, the invention discloses a heating step that is carried while the implant is in a vacuum.
In another aspect of this invention, there is described the heating method of implants to reduce residual free radicals. The medical device comprising a polymeric raw material, such as UHMWPE, is generally heated to a temperature of about 137°C or more. The medical device is kept heated in the inert medium until the concentration of the residual free radicals is reduced to acceptable levels as measured by electron spin resonance. It is preferred that the concentration of the residual free radicals is at or below the detection limit of electron spin resonance. Soaking Process:
The present invention also provides conditions of treatment of reducing residual free radicals by soaking the implant in a sensitizing atmosphere such as immersing the implant into acetylene or another sensitizmg gas which can be pressured into the implant. In this process, the sensitizing gas diffuses in and reacts with residual free radicals forming additional cross-links. The invention further relates to a process, if necessary, to accelerate the diffusion of the sensitizing gas by increasing temperature of the chamber that holds the implant and the gas.
The term "contacted" in this context includes close physical proximity with or touching such that the sensitizing agent can perform its intended function. Preferably, a polyethylene composition or pre-form is sufficiently contacted such that it is soaked in the sensitizing agent, which ensures that the contact is sufficient. Soaking is defined as placing the sample in a specific environment for a sufficient period of time at an appropriate temperature. The environment include a sensitizing gas, such as acetylene, ethylene, or a similar gas or mixture of gases, or a sensitizing liquid, for example, a diene. The environment is heated to a temperature ranging from room temperature to a temperature above the melting point of the polymeric material. The contact period ranges from at least about 1 minute to several weeks and the duration depending on the temperature of the environment. In one aspect, the contact time period at room temperature is about 24 hours to about 48 hours and preferably about 24 hours.
A "sensitizing environment" refers to a mixture of gases and/or liquids (at room temperature) that contain sensitizing gaseous and/or liquid component(s) that can react with residual free radicals to assist in the recombination and elimination of the residual free radicals. The gases may be acetylene, chloro-trifluoro ethylene (CTFE), ethylene, or like. The gases or the mixtures of gases thereof may contain noble gases such as nitrogen, argon, neon and like. Other gases such as, carbon dioxide or carbon monoxide may also be present in the mixture. In applications where the surface of a treated material is machined away during the device manufacture, the gas blend could also contain oxidizing gases such as oxygen. The sensitizing environment can be dienes with different number of carbons, or mixtures of liquids and/or gases thereof. An example of a sensitizing liquid component is octadiene or other dienes, which can be mixed with other sensitizing liquids and/or non-sensitizing liquids such as a hexane or a heptane. A sensitizing environment can include a sensitizing gas, such as acetylene, ethylene, or a similar gas or mixture of gases, or a sensitizing liquid, for example, a diene. The environment is heated to a temperature ranging from room temperature to a temperature above the melting-point of the polymeric material.
The invention is further described by the following examples, which do not limit the invention in any manner.
Examples
Example 1: Compression molding, mechanical interlocks in medical devices, and irradiation of hybrid components:
Figure 1 diagrams sequential steps in compression molding of polyethylene powder to a metallic mesh. Figure 1 Step-1 shows a mesh-like surface (20) on the other side facing the polyethylene powder (10) is compression molded. Step-2 shows the consolidated polyethylene (15) taking a shape at the interface that penetrates into the mesh and Step-3 depicting consolidated polyethylene partially penetrating the metallic mesh and forming a hybrid component (30) with an interlocking interface. The mesh surface on the other side is continuous through the interface or intermittent. Following compression molding, the hybrid component is irradiated, melted and then machined for final shape.
Polyethylene resin powder was placed on top of a metallic mesh as shown in
Figure 1 Step-1. These were then placed in a mold as shown in Step-2, heated to above the melting point and consolidated under pressure. Subsequent to pressing, the polyethylene was allowed to cool down to room temperature under pressure. The consolidated polyethylene was then removed from the mold to be irradiated to crosslink the polyethylene and melted to reduce the concentration of residual free radicals to an undetectable level. A final implant shape was then machined and the implant was sterilized with EtO, gas plasma or autoclaved. Extrusion of polyethylene on the other side of the mesh can be avoided by either having a solid layer of thin metal half-way through the mesh or by filling the empty pores on the backside with a space filling material that can be removed subsequent to the consolidation.
Referring to Figures 2-5, the diagram in Figure 2 shows an example of a compression molded polyethylene (60) to a metallic back (40) containing metallic mesh (20) and a metallic backed Patella (70). Figure 3 shows an example of a compression molded of polyethylene (120) to a metal shell (100) containing metallic mesh (20). Figures 4 and 5 show examples of metal trays (40) containing metallic mesh (20) and undercuts or recess (80), respectively, to secure compression molded polyethylene. A surface with geometries, for example, mesh, recess, undercuts, grooves (see
Figures 4 and 5), or the like that allowed the polyethylene resin powder to penetrate, consolidate and take the shape of the surface such that the mechanical interlocking is achieved and resulted into a hybrid component (30) having strong interlocking interface (see Figure 1). As shown in Figure 2, polyethylene resin powder was consolidated to a mesh surface that has a solid metal backing for the manufacture of a patellar implant. The consolidated group was irradiated to crosslink the polyethylene and to sterilize the polyethylene/metallic mesh interface. Subsequently, the implant was melted to reduce the concentration of residual free radicals. The articulating surface of the implant was then machined to the desired geometry. Finally the implant was sterilized using a gas (ethylene oxide, gas plasma, or the other gas).
Figure 3 shows the same as in Figure 2, however, polyethylene resin powder was consolidated to a mesh surface in a different geometry.
Figures 4 and 5 depict two alternative counterface interlocking geometries. Figure 4 shows an intermittent metallic mesh on a solid metallic back, wherein the mesh acts as the interlocking counterface. The intermittent mesh on a solid metal backing can be used in a variety of geometries such as a tibial knee insert, bipolar acetabular component, acetabular component, patellar components, or shoulder glenoid. Figure 5 shows an undercut geometry into which polyethylene provides interfacial strength between the polyethylene and the metallic back. The shape and dimensions of the undercut can be varied to improve the interface strength. This type of interface geometry can be used in a variety of flat, concave, or convex interface geometries in a variety of implants.
As shown in Figures 2, 3, 4 and 5, the consolidated polyethylene can penetrate the full thickness of the metallic mesh. However, sufficient interface strength can be achieved even with partial penetration. Figure 2 depicts a combination of interface surfaces, for example, a mesh (20) and a macro-geometries is combined to tailor an interface of preferred strength.
A surface with geometries such as recess, undercuts (80), grooves (see Figures 4-5) or like that allowed the polymeric material to penetrate and consolidate taking the shape of that surface such that the mechanical interlocking achieved allows for a strong interface.
Figure 3 shows a polyethylene (120), which is direct compression molded to a metallic mesh counterface (20) and/or a metal back metal shell (100) with a mechanical interlock, thereby forming a hybrid component. The hybrid component was irradiated using ionizing radiation to a desired dose level, for example, about 25 kGy to about 1000 kGy, preferably between about 50 kGy and about 100 kGy. Irradiation crosslinked the polymer, as well as sterilized the interface that is in close contact between the polyethylene and counterface. During the process of irradiation,*' residual free radicals were generated, which may compromise the long-term oxidative stability of the polymer and in vivo device performance. Therefore, a melting step at this point in the fabrication is used to quench the residual free radicals. Because the resin powder was consolidated into the shape of the interface, which sets the shape memory of the polymer, the polyethylene did not separate from the counterface.
Example 2: Melting of interlocked interface in a non-oxidizing medium: A medical device, for example, manufactured following a process as described in the examples 1 or 2, was immersed in a non-oxidizing medium such as inert gas or inert fluid. The medium was heated to above the melting point of the irradiated UHMWPE (about >137°C) to eliminate the crystalline matter and allowed for the recombination/elimination of the residual free radicals. Because the shape memory of the compression molded polymer is set at the mechanically interlocked interface and that memory is strengthened by the crosslinking step, there was no significant separation at the interface between the polyethylene and the counterface.
Example 3: Post-melting machining and sterilization:
The interface between the metal and the polymer becomes sterile during the high dose irradiation used to manufacture a hybrid component following a process as described above in examples 1 and 2. When there is a substantial oxidation of the outside surface of the polyethylene, one can further machine this surface to remove the oxidized surface layer. This requires to oversize the outside surfaces (near net- shape) or not even forming the outside surface geometry during the compression molding process. In the case a post-melting machining step, the melting step also can be carried out in an inert gas.
At this point in the fabrication of the device, because the interface is sterile but the rest of the component is not, the implant is sterilized with ethylene oxide, gas plasma, or the other gas.
Example 4: Preparation of a polyethylene/mesh assembly by high temperature compression of a consolidated polyethylene cylinder to a metallic mesh:
A custom-built, two-piece stainless steel die (Figure 6), . with central cylindrical cavity (diam. = 11 mm) and accompanying stainless steel plunger (diam. = 10.5 mm) was used in the compression molding experiments.
A SS304 woven wire mesh (Southwestern Wire Cloth, Tulsa, OK) with 20 mesh per inch, 0.016" wire diameter, 0.034" opening width, 46.2% open area was used along with a machined cylindrical pin of GUR 1050 ultra-high molecular weight (Perplas Ltd., Bacup, UK) with a diameter of 9 mm and height of 13 mm were used in the compression experiments.
First, a section of mesh was cut to drop into the central cylindrical cavity of the die. Next, the UHWMPE pin was placed inside the cavity. The plunger was added atop of the pin/mesh tandem, and the entire die assembly was heated to 160 °C under vacuum (Lindberg/Blue Vacuum Oven, Asheville, NC), allowing the UHMWPE pin to fully melt before pressing. Following heating, approximately 3,500 lbs of load was applied to the plunger using a Carver Hydraulic Press (Unit #3912, Wabash, IN). Once this maximum load level was reached, the die assembly was held under load for approximately 20 minutes, allowing load to decay as consolidation and/or creep occurred.
Five pin/mesh assemblies were fabricated. A typical example showing the mesh incorporated into the UHMWPE pin is displayed in Figure 7.
Example 5: Compression molding of polyethylene resin powder to a metallic mesh:
A custom-built, two-piece stainless steel die (Figure 6), with central cylindrical cavity (diam. = 11 mm) and accompanying stainless steel plunger (diam. = 10.5 mm) was used in the compression molding experiments. A SS304 woven wire mesh (Southwestern Wire Cloth, Tulsa, OK) with 60 mesh per inch, 0.0075" wire diameter, 0.0092" opening width, and 30.5% open area was used along with GUR 1050 ultra-high molecular weight virgin resin (Perplas Ltd., Bacup, UK) flakes were used in the consolidation experiments.
First, a section of mesh was cut to drop into the central cylindrical cavity of the die. Next, the cavity was densely packed with UHMWPE resin powder. The plunger was added atop of the resin/mesh tandem, and the entire die assembly was heated to 210°C under vacuum (Lindberg/Blue Vacuum Oven, Asheville, NC), allowing samples to fully melt before pressing. Following heating approximately 3,500 lbs of load was applied to the plunger using a Carver Hydraulic Press (Unit #3912, Wabash, IN). Once this maximum load level was reached, the die assembly was held under load for approximately 20 minutes, allowing load to' decay as consolidation and/or creep occurred.
Five compression molded resin/mesh assemblies were fabricated. A typical example showing the mesh incorporated into polyethylene is displayed in Figure 8.
Example 6: Fabrication of a crosslinked UHMWPE incorporated into a metal-mesh backing with a sterile interface:
Five of the UHMWPE resin/mesh assemblies described in Example 5 were packaged in a metallized foil pouch in vacuum and subjected to 100 kGy gamma irradiation under vacuum (Steris-Isomedix, Northborough, MA). The faces of the UHMWPE resin/mesh assemblies that incorporated the mesh were photographed after irradiation. The UHMWPE resin/mesh assemblies were then heated to 160°C in a vacuum to eliminate the residual free radicals generated by the gamma irradiation. The faces containing the mesh were photographed again following the melting. In all five samples the mesh was retained in the consolidated UHMWPE following the melting. In the present example, the shape memory of the UHMWPE was set to a geometry that included the mesh unlike what was observed in Example 4, where the shape memory recovery of the original dimensions of the pin led to the dissociation of the mesh. Figures 9-10 show examples of the retention of the mesh following post- irradiation melting.
Therefore, the polyethylene resin needs to be consolidated to a original shape memory that also includes the metallic structure of interest to avoid dissociation following post-irradiation melting.
It is to be understood that the description, specific examples and data, while indicating exemplary embodiments, are given by way of illustration and are not intended to limit the present invention. Various changes and modifications within the present invention will become apparent to the skilled artisan from the discussion, disclosure and data contained herein, and thus are considered part of the invention.

Claims

What is claimed is:
1. A method of making a medical implant containing crosslinked polyethylene that is in contact with another piece, thereby forming an interface, wherein the method comprises: a) compression molding of polyethylene to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the crosslinked polyethylene by heating the hybrid material above the melting point of the crosslinked polyethylene.
2. The method according to claim 1, wherein the polyethylene comprises polyethylene resin powder, flakes, or particles, and wherein the polyethylene is compression molded to a metallic back.
3. The method according to claim 1, wherein the metallic back is shaped to serve as a fixation interface with the bone, through either bony growth or by bone cement.
4. The method according to claim 3, wherein the shapes are in the form of acetabular liner, tibial tray for total or unicompartmental knee implants, patella tray, glenoid component, ankle, elbow or finger component.
5. The method according to claim 1, wherein the irradiation is carried out in an atmosphere containing between about 1 % and about 22% oxygen.
6. The method according to claim 1, wherein the irradiation is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
7. The method according to claim 1, wherein the irradiation is carried out in a vacuum.
8. The method according to claim 1, wherein the heating temperature is above about 137°C.
9. The method according to claim 1, wherein the heating is carried out in an atmosphere containing between about 1% and about 22% oxygen.
10. The method according to claim 1, wherein the heating is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
11. The method according to claim 1 , wherein the heating is carried out in a vacuum.
12. The method according to claim 1, wherein the radiation dose is between about 25 and about 1000 kGy.
13. The method according to claim 1, wherein the radiation dose is about 50 kGy, about 100 kGy, about 200 kGy, about 300 kGy, about 400 kGy, about 500 kGy, about 600 kGy, about 700 kGy, about 800 kGy, about 900 kGy, or about 1000 kGy.
14. The method according to claim 1, wherein the piece is metallic or non metallic.
15. The method according to claim 1, wherein the piece is a metallic or a non metallic back, a ceramic, a tibial tray, a patella tray, or an acetabular shell.
16. The method of claim 1, wherein the piece comprises a metallic or a non-metallic mesh, an undercut, a recess or a combination thereof. . .
17. The method according to claim 1, wherein the interface is a metal-polymer.
18. The polymer according to claim 17 is a polyolefin.
19. The polyolefin of claim 18 is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
20. The method according to claim 1, wherein the implant comprises medical devices selected from the group consisting of bipolar hip replacements, tibial knee inserts with reinforcing metallic and polyethylene posts, and an implant that contains an interface that cannot be sterilized by a gas sterilization method.
21. The method according to claim 1, wherein the ionizing radiation is a gamma irradiation in a nitrogen atmosphere.
22. The method according to claim 1, wherein the ionizing radiation is an electron beam irradiation in a nitrogen atmosphere.
23. The method according to claim 1, wherein the reduction of free radicals in the crosslinked polyethylene is achieved by heating the implant in contact with a non- oxidizing medium.
24. The method according to claim 1, wherein the reduction of free radicals in the crosslinked polyethylene is achieved by contacting with a non-oxidizing medium and heating the medium to above the melting temperature of the irradiated polyethylene.
25. The method according to claim 24, wherein the non-oxidizing medium is an inert gas.
26. The method according to claim 24, wherein the non-oxidizing medium is an inert fluid.
27. The method according to claim -24, wherein the medium is a polyunsaturated hydrocarbon selected from the group consisting of: acetylenic hydrocarbons such as acetylene; conjugated or unconjugated olefinic hydrocarbons such as butadiene and (meth)acrylate monomers; and sulphur monochloride with chloro-tri-fluoroethylene (CTFE) or acetylene.
28. The method according to claim 1, wherein the reduction of free radicals in the crosslinked polyethylene is achieved by heating the implant to above the melting point of the polyethylene.
29. The method according to claim 1, wherein the reduction of free radicals in crosslinked polyethylene is achieved under an inert condition having no more than about 1% oxygen.
30. The method according to claim 29, wherein the condition is an inert atmosphere or a vacuum.
31. The method according to claim 30, wherein the inert atmosphere contains a gas selected from the group consisting of: nitrogen; argon; helium; and neon.
32. The method according to claim 1, wherein the implant is further sterilized by a gas.
33. The method according to claim 32, wherein the gas is ethylene oxide, gas plasma, or other gas.
34. The method according to claim 33, wherein ethylene oxide is used for sterilization.
35. The method according to claim 33, wherein gas plasma is used for sterilization.
36. A method of forming and sterilizing a medical implant containing crosslinked polyethylene that is in contact with another piece, thereby forming an interface, wherein the method comprises the steps of: a) compression molding of polyethylene resin powder to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; c) reducing free radicals in the crosslinked polyethylene by heating the hybrid material above the melting point of the crosslinked polyethylene; and d) sterilizing the medical implant with a gas.
37. The method according to claim 36, wherein the irradiation is carried out in an atmosphere containing between about 1% and about 22% oxygen.
38. The method according to claim 36, wherein the irradiation is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
39. The method according to claim 36, wherein the irradiation is carried out in a vacuum.
40. The method according to claim 36, wherein the heating is carried out in an atmosphere containing between about 1% and about 22% oxygen.
41. The method according to claim 36, wherein the heating is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
42. The method according to claim 36, wherein the heating is carried out in a vacuum.
43. A method of forming and sterilizing a medical implant containing crosslinked polyethylene that is in contact with another piece, thereby forming an interface, wherein the method comprises the steps of: a) compression molding of polyethylene to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; c) reducing free radicals in the crosslinked polyethylene by heating the hybrid material above the melting point of the crosslinked polyethylene; and d) sterilizing the medical implant with a gas.
44. The method according to claim 43, wherein the irradiation is carried out in an atmosphere containing between about 1% and about 22% oxygen.
45. The method according to claim 43, wherein the irradiation is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
46. The method according to claim 43, wherein the irradiation is carried out in a vacuum.
47. The method according to claim 43, wherein the heating is carried out in an atmosphere containing between about 1 % and about 22% oxygen.
48. The method according to claim 43, wherein the heating is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
49. The method according to claim 43, wherein the heating is carried out in a vacuum.
50. A medical implant containing crosslinked polyethylene that is in contact with another piece, thereby forming an interface, obtainable by: a) compression molding of polyethylene resin powder to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the crosslinked polyethylene by heating the hybrid material above the melting point of the crosslinked polyethylene.
51. The medical implant of claim 50, wherein the polyethylene is in contact with another piece, thereby forming an interlocking interface.
52. The medical implant of claim 50, wherein the interface is rendered substantially ' sterile.
53. The method according to claim 50, wherein the irradiation is carried out in an atmosphere containing between about 1% and about 22% oxygen.
54. The method according to claim 50, wherein the irradiation is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
55. The method according to claim 50, wherein the irradiation is carried out in a vacuum.
56. The method according to claim 50, wherein the heating is carried out in an atmosphere containing between about 1 % and about 22% oxygen.
57. The method according to claim 50, wherein the heating is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
58. The method according to claim 50, wherein the heating is carried out in a vacuum.
59. A medical implant containing crosslinked polyethylene that is in contact with another piece, thereby forming an interface, obtainable by: a) compression molding of polyethylene to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the crosslinked polyethylene by heating the hybrid material above the melting point of the crosslinked polyethylene.
60. The medical implant of claim 59, wherein the polyethylene is in contact with another piece, thereby forming an interlocking interface.
61. The medical implant of claim 59, wherein the interface is substantially sterile.
62. The method according to claim 59, wherein the irradiation is carried out in an atmosphere containing between about 1% and about 22% oxygen.
63. The method according to claim 59, wherein the irradiation is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
64. The method according to claim 59, wherein the irradiation is carried out in a vacuum.
65. The method according to claim 59, wherein the heating is carried out in an atmosphere containing between about 1 % and about 22% oxygen.
66. The method according to claim 59, wherein the heating is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
67. The method according to claim 59, wherein the heating is carried out in a vacuum.
68. An interface obtainable by: a) compression molding of polyethylene resin powder to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the polyethylene by heating the hybrid material above the melting point of the polyethylene.
69. The interface according to claim 68, wherein the piece is a metallic or a non- metallic component.
70. The interface according to claim 68, wherein the piece is a metallic back, a non- metallic back, a tibial tray, a patella tray, or an acetabular shell.
71. The interface of claim 68, wherein the piece comprises a metallic mesh, a non- metallic mesh, an undercut, a recess or a combination thereof.
72. The interface according to claim 68, wherein the interface is a metal-polymer.
73. The polymer according to claim 72 is a polyolefin.
74. The polyolefin of claim 73 is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
75. The method according to claim 68, wherein the irradiation is carried out in an atmosphere containing between about 1% and about 22% oxygen.
76. The method according to claim 68, wherein the irradiation is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
77. The method according to claim 68, wherein the irradiation is carried out in a vacuum.
78. The method according to claim 68, wherein the heating is carried out in an atmosphere containing between about 1% and about 22% oxygen.
79. The method according to claim 68, wherein the heating is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
80. The method according to claim 68, wherein the heating is carried out in a vacuum.
81. An interface obtainable by: a) compression molding of polyethylene to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the polyethylene by heating the hybrid material above the melting point of the polyethylene.
82. The method according to claim 81, wherein the irradiation is carried out in an atmosphere containing between about 1% and about 22% oxygen.
83. The method according to claim 81, wherein the irradiation is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
84. The method according to claim 81, wherein the irradiation is carried out in a vacuum.
85. The method according to claim 81, wherein the heating is carried out in an atmosphere containing between about 1% and about 22% oxygen.
86. The method according to claim 81, wherein the heating is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
87. The method according to claim 81, wherein the heating is carried out . in a vacuum.
88. The interface according to claim 81, wherein the piece is a metallic or a non- metallic component.
89. The interface according to claim 81, wherein the piece is a metallic back, a non- metallic back, a tibial tray, a patella tray, or an acetabular shell.
90. The interface of claim 81, wherein the piece comprises a metallic mesh, a non- metallic mesh, an undercut, a recess or a combination thereof.
91. The interface according to claim 81, wherein the interface is a metal-polymer.
92. The polymer according to claim 91 is a polyolefin.
93. The polyolefin of claim 91 is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
94. An interface obtainable by: a) compression molding of resin powder to another piece, thereby forming an interlocked hybrid material; and b) irradiating the hybrid material by ionizing radiation, wherein the interface is substantially sterile.
95. The method according to claim 94, wherein the irradiation is carried out in an atmosphere containing between about 1 % and about 22% oxygen.
96. The method according to claim 94, wherein the irradiation is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
97. The method according to claim 94, wherein the irradiation is carried out in a vacuum.
98. The interface according to claim 94, wherein the piece is a metallic or a non- metallic component.
99. The interface according to claim 94, wherein the piece is a metallic back, a non- metallic back, a tibial tray, a patella tray, or an acetabular shell.
100. The interface of claim 94, wherein the piece comprises a metallic mesh, a non- metallic mesh, an undercut, a recess or a combination thereof.
101. The interface according to claim 94, wherein the interface is a metal -polymer.
102. The polymer according to claim 101 is a polyolefin.
103. The polyolefin of claim 102 is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
104. An interface obtainable by: a) compression molding of polyethylene to another piece, thereby forming an interlocked hybrid material; and b) in-adiating the hybrid material by ionizing radiation, wherein the interface is substantially sterile.
105. The method according to claim 104, wherein the irradiation is carried out in an atmosphere containing between about 1% and about 22% oxygen.
106. The method according to claim 104, wherein the irradiation is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
107. The method according to claim 104, wherein the irradiation is carried out in a vacuum.
108. The interface according to claim 104, wherein the piece is a metallic or a non- metallic component.
109. The interface according to claim 104, wherein the piece is a metallic back, a non-metallic back, a tibial tray, a patella tray, or an acetabular shell.
110. The interface of claim 104, wherein the piece comprises a metallic mesh, a non- metallic mesh, an undercut, a recess or a combination thereof.
111. The interface according to claim 104, wherein the interface is a metal-polymer.
112. The polymer according.to claim 111 is a polyolefin.
113. The polyolefin of claim 112 is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
114. An interface obtainable by: a) compression molding of polyethylene resin powder to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the polyethylene by heating the hybrid material above the melting point of the polyethylene, wherein the interface is substantially sterile.
115. The method according to claim 1 14, wherein the irradiation is carried out in an atmosphere containing between about 1 % and about 22% oxygen.
116. The method according to claim 114, wherein the irradiation is carried out in an. inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
117. The method accordmg to claim 114, wherein the irradiation is carried out in a vacuum.
118. The method according to claim 114, wherein the heating is carried out in an atmosphere containing between about 1% and about 22% oxygen.
119. The method according to claim 114, wherein the heating is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
120. The method according to claim 114, wherein the heating is carried out in a vacuum.
121. The interface according to claim 114, wherein the piece is a metallic or a non metallic component.
122. The interface according to claim 114, wherein the piece is a metallic back, a non-metallic back, a tibial tray, a patella tray, or an acetabular shell.
123. The interface of claim 114, wherein the piece comprises a metallic mesh, a non- metallic mesh, an undercut, a recess or a combination thereof.
124. The interface according to claim 114, wherein the interface is a metal-polymer.
125. The polymer according to claim 124 is a polyolefin.
126. The polyolefin of claim 125 is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
127. An interface obtainable by: a) compression molding of polyethylene to another piece, thereby forming an interlocked hybrid material; b) irradiating the hybrid material by ionizing radiation; and c) reducing free radicals in the polyethylene by heating the hybrid material above the melting point of the polyethylene, wherein the interface is substantially sterile.
128. The method according to claim 127, wherein the irradiation is carried out in an atmosphere containing between about 1% and about 22% oxygen.
129. The method according to claim 127, wherein the irradiation is earned out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
130. The method according to claim 127, wherein the irradiation is carried out in a vacuum.
131. The method according to claim 127, wherein the heating is carried out in an atmosphere containing between about 1% and about 22% oxygen.
132. The method according to claim 127, wherein the heating is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
133. The method according to claim 127, wherein the heating is carried out in a vacuum.
134. The interface according to claim 127, wherein the piece is a metallic or a non- metallic component.
135. The interface according to claim 127, wherein the piece is a metallic back, a non-metallic back, a tibial tray, a patella tray, or an acetabular shell.
136. The interface of claim 127, wherein the piece comprises a metallic mesh, a non- metallic mesh, an undercut, a recess or a combination thereof.
137. The interface according to claim 127, wherein the interface is a metal-polymer.
138. The polymer according to claim 137 is a polyolefin.
139. The polyolefin of claim 138 is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
140. An acetabular assembly comprising: a) polyethylene compression molded to another piece, thereby forming an interlocked hybrid component; b) a substantially sterile interface; and c) a metallic back.
141. The assembly of claim 140, wherein the piece comprising a metallic mesh, a non-metallic mesh, an undercut, a recess, or a combination thereof.
142. The assembly of claim 140, wherein the polyethylene comprises powder, flakes, or particles, and wherein the polyethylene is compression molded to a counterface.
143. The assembly of claim 142, wherein the counterface is metallic back, a metallic mesh, a tibial tray, a patella tray, or an acetabular shell.
144. The assembly of claim 142, wherein the counterface is shaped to serve as a fixation interface with the bone, through either bony growth or by bone cement.
145. The assembly of claim 144, wherein the shapes are in the form of acetabular liner, tibial tray for total or unicompartmental knee implants, patella tray, glenoid component, ankle, elbow or finger component.
146. The assembly of claim 140, wherein the polyethylene is crosslinked by ionizing radiation.
147. The method according to claim 146, wherein the irradiation is carried out in an atmosphere containing between about 1% and about 22% oxygen.
148. The method according to claim 146, wherein the irradiation is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
149. The method according to claim 146, wherein the irradiation is carried out in a vacuum.
150. The assembly of claim 146, wherein the radiation dose is between about 25 and about 1000 kGy.
151. The assembly of claim 146, wherein the radiation dose is about 50 kGy, about 100 kGy, about 200 kGy, about 300 kGy, about 400 kGy, about 500 kGy, about 600 kGy, about 700 kGy, about 800 kGy, about 900 kGy, or about 1000 kGy.
152. The assembly of claim 140, wherein the hybrid component is heated to a temperature above the melting point of the polyethylene.
153. The method according to claim 152, wherein the heating is carried out in an atmosphere containing between about 1 % and about 22% oxygen.
154. The method according to claim 152, wherein the heating is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
155. The method according to claim 152, wherein the heating is carried out in a vacuum.
156. The assembly of claim 152, wherein the heating temperature is above about 137°C.
157. An acetabular assembly comprising: a) a polyethylene acetabular liner compression molded to another piece, thereby forming an interlocked hybrid material; b) a substantially sterile interface; and c) a metallic back.
158. The assembly of claim 157, wherein the comprising a metallic mesh, a non- metallic mesh, an undercut, a recess, or a combination thereof.
159. The assembly of claim 157, wherein the polyethylene comprises powder, flakes, or particles, and wherein the polyethylene is compression molded to a counterface.
160. The assembly of claim 159, wherein the counterface is metallic back, a metallic mesh, a tibial tray, a patella tray, or an acetabular shell.
161. The assembly of claim 159, wherein the counterface is shaped to serve as a fixation interface with the bone, through either bony growth or by bone cement.
162. The assembly of claim 161, wherein the shapes are in the form of acetabular liner, tibial tray for total or unicompartmental knee implants, patella tray, glenoid component, ankle, elbow or finger component.
163. The assembly of claim 157, wherein the polyethylene is crosslinked by ionizing radiation.
164. The method according to claim 163, wherein the irradiation is carried out in an atmosphere containing between about 1% and about 22% oxygen.
165.. The method according to claim 163, wherein the irradiation is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
166. The method according to claim 163, wherein the irradiation is carried out in a vacuum.
167. The assembly of claim 163, wherein the radiation dose is between about 25 and about 1000 kGy.
168. The assembly of claim 163, wherein the radiation dose is about 50 kGy, about 100 kGy, about 200 kGy, about 300 kGy, about 400 kGy, about 500 kGy, about 600 kGy, about 700 kGy, about 800 kGy, about 900 kGy, or about 1000 kGy.
169. The assembly of claim 157, wherein the hybrid component is heated to a temperature above the melting point of the polyethylene.
170. The method according to claim 169, wherein the heating is carried out in an atmosphere containing between about 1% and about 22% oxygen.
171. The method according to claim 169, wherein the heating is carried out in an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
172. The method according to claim 169, wherein the heating is carried out in a vacuum.
173. The assembly of claim 169, wherein the heating temperature is above about 137°C.
174. A medical implant comprising crosslinked polyethylene having substantially no detectable free radicals; and a sterile interlocking interface.
175. The implant of claim 174, wherein the polyethylene is in contact with another piece, thereby forming an interface.
176. The implant of claim 174, wherein the polyethylene is compression molded to another piece, thereby forming a mechanically interlocked hybrid material.
177. The implant of claim 174, wherein the polyethylene resin powder is compression molded to another piece, thereby forming a mechanically interlocked hybrid material.
178. The implant of claim 174, wherein the polyethylene is in contact with another piece, thereby forming an interlocking interface.
179. The implant of claim 178, wherein the piece is a metallic or a non-metallic component.
180. The implant of claim 178, wherein the piece is a metallic back, a non-metallic back, a tibial tray, a patella tray, or an acetabular shell.
181. The implant of claim 178, wherein the piece comprises a metallic mesh, a non- metallic mesh, an undercut, a recess or a combination thereof.
182. The implant of claim 174, wherein the interface is a metal-polymer.
183. The polyethylene according to claim 174 is a polyolefin.
184. The polyolefin of claim 183 is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
185. The implant of claim 174, wherein the polyethylene comprises powder, flakes, or particles, and wherein the polyethylene is compression molded to a counterface.
PCT/US2003/018053 2002-06-21 2003-06-10 Metal back or mesh crosslinking WO2004000159A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/518,593 US20050146070A1 (en) 2002-06-21 2003-06-10 Meta lback or mesh crosslinking
AU2003245420A AU2003245420A1 (en) 2002-06-21 2003-06-10 Metal back or mesh crosslinking

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US39012002P 2002-06-21 2002-06-21
US60/390,120 2002-06-21
US42470902P 2002-11-08 2002-11-08
US60/424,709 2002-11-08

Publications (2)

Publication Number Publication Date
WO2004000159A2 true WO2004000159A2 (en) 2003-12-31
WO2004000159A3 WO2004000159A3 (en) 2004-12-29

Family

ID=30003138

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/018053 WO2004000159A2 (en) 2002-06-21 2003-06-10 Metal back or mesh crosslinking

Country Status (3)

Country Link
US (1) US20050146070A1 (en)
AU (1) AU2003245420A1 (en)
WO (1) WO2004000159A2 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006013536A1 (en) * 2004-07-29 2006-02-09 De Villiers, Malan Annealing of radiation crosslinked polymers
EP2208739A1 (en) 2005-08-22 2010-07-21 The General Hospital Corporation d/b/a Massachusetts General Hospital Highly crystalline polyethylene
CN102824232A (en) * 2012-08-28 2012-12-19 中国科学院宁波材料技术与工程研究所 Anti-oxidation artificial joint prosthesis and preparation method thereof
US8426486B2 (en) 2004-02-03 2013-04-23 The General Hospital Corporation Highly crystalline cross-linked oxidation-resistant polyethylene
US10105132B2 (en) 2005-05-20 2018-10-23 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10130353B2 (en) 2012-06-29 2018-11-20 Neotract, Inc. Flexible system for delivering an anchor
US10143461B2 (en) 2005-05-20 2018-12-04 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US10195014B2 (en) 2005-05-20 2019-02-05 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10265061B2 (en) 2005-05-20 2019-04-23 Neotract, Inc. Latching anchor device
US10292801B2 (en) 2012-03-29 2019-05-21 Neotract, Inc. System for delivering anchors for treating incontinence
US10299780B2 (en) 2005-05-20 2019-05-28 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US10349932B2 (en) 2013-03-15 2019-07-16 Neotract, Inc. Anchor delivery system
US10426509B2 (en) 2005-05-20 2019-10-01 Neotract, Inc. Median lobe destruction apparatus and method
US10492792B2 (en) 2005-05-20 2019-12-03 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10925587B2 (en) 2005-05-20 2021-02-23 Neotract, Inc. Anchor delivery system
US11298115B2 (en) 2020-08-03 2022-04-12 Teleflex Life Sciences Limited Handle and cartridge system for medical interventions
US11672520B2 (en) 2017-12-23 2023-06-13 Teleflex Life Sciences Limited Expandable tissue engagement apparatus and method

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7938861B2 (en) * 2003-04-15 2011-05-10 Depuy Products, Inc. Implantable orthopaedic device and method for making the same
US8298292B2 (en) * 2003-04-16 2012-10-30 Howmedica Osteonics Corp. Craniofacial implant
KR20100102753A (en) * 2003-04-16 2010-09-24 포렉스 서지칼, 인크. Craniofacial implant
ATE454110T1 (en) * 2003-06-27 2010-01-15 Abs Corp SYSTEM FOR ANKLE JOINT ARTHROPLASTY
ES2441608T3 (en) * 2005-08-18 2014-02-05 Zimmer Gmbh Ultra-high molecular weight polyethylene articles and methods for forming ultra-high molecular weight polyethylene articles
ES2378721T3 (en) 2007-04-10 2012-04-17 Zimmer, Inc. Ultra high molecular weight crosslinked polyethylene stabilized by antioxidants for applications in medical devices
US8664290B2 (en) 2007-04-10 2014-03-04 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
CA2697761A1 (en) * 2007-08-27 2009-03-05 Vladimir Shur Knee prosthesis
EP2207821B1 (en) * 2007-11-06 2011-05-25 DSM IP Assets B.V. Process for producing (ultra) high molecular weight polyethylene
US8652212B2 (en) 2008-01-30 2014-02-18 Zimmer, Inc. Orthopedic component of low stiffness
DE102008037201A1 (en) * 2008-08-11 2010-04-15 Alfred Buck Artificial joint
EP2346941A1 (en) * 2008-11-20 2011-07-27 Zimmer GmbH Polyethylene materials
US8007539B2 (en) * 2008-12-08 2011-08-30 Biomet Manufacturing Corp. Metal-on-metal modular hybrid liner
JP4806717B2 (en) * 2009-06-25 2011-11-02 株式会社沖データ Image processing system
US8123813B2 (en) 2009-07-14 2012-02-28 Biomet Manufacturing Corp. Pyrocarbon orthopedic implant
GB0922339D0 (en) 2009-12-21 2010-02-03 Mcminn Derek J W Acetabular cup prothesis and introducer thereof
US8399535B2 (en) 2010-06-10 2013-03-19 Zimmer, Inc. Polymer [[s]] compositions including an antioxidant
US9044195B2 (en) 2013-05-02 2015-06-02 University Of South Florida Implantable sonic windows
US9708467B2 (en) 2013-10-01 2017-07-18 Zimmer, Inc. Polymer compositions comprising one or more protected antioxidants
US10184031B2 (en) 2014-03-12 2019-01-22 Zimmer, Inc. Melt-stabilized ultra high molecular weight polyethylene and method of making the same
CA2969751C (en) 2014-12-03 2020-09-22 Zimmer, Inc. Antioxidant-infused ultra high molecular weight polyethylene
US11376128B2 (en) 2018-12-31 2022-07-05 Depuy Ireland Unlimited Company Acetabular orthopaedic prosthesis and method
US11628066B2 (en) 2019-12-11 2023-04-18 Depuy Ireland Unlimited Company Ceramic acetabular shell liner with a metal ring having a lead-in surface
US11291549B2 (en) 2019-12-11 2022-04-05 Depuy Ireland Unlimited Company Ceramic acetabular shell liners with augments
DE102020211582A1 (en) * 2020-09-16 2022-03-17 Karl Leibinger Medizintechnik Gmbh & Co. Kg Implantable jaw joint prosthesis and corresponding manufacturing method
WO2023115172A1 (en) * 2021-12-20 2023-06-29 Stainer Daniel Process of manufacturing an acetabular insert

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879400A (en) * 1996-02-13 1999-03-09 Massachusetts Institute Of Technology Melt-irradiated ultra high molecular weight polyethylene prosthetic devices
US6245276B1 (en) * 1999-06-08 2001-06-12 Depuy Orthopaedics, Inc. Method for molding a cross-linked preform
US6547828B2 (en) * 2001-02-23 2003-04-15 Smith & Nephew, Inc. Cross-linked ultra-high molecular weight polyethylene for medical implant use
US6566451B2 (en) * 2000-02-29 2003-05-20 Howmedica Osteonics Corp. Methods of improving the wear resistance of prosthetic medical devices

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5110625B2 (en) * 1972-05-01 1976-04-05
US4164458A (en) * 1977-03-07 1979-08-14 Allied Chemical Corporation Production of radiation crosslinked polymeric compositions using diacetylenes
US4971761A (en) * 1989-03-06 1990-11-20 Mdt Corporation Temperature control method for an ethylene oxide sterilization cycle
US5024670A (en) * 1989-10-02 1991-06-18 Depuy, Division Of Boehringer Mannheim Corporation Polymeric bearing component
GB9420071D0 (en) * 1994-10-05 1994-11-16 Howmedica Metal backing for inclusion in the manufacture of a prosthetic component
US8865788B2 (en) * 1996-02-13 2014-10-21 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
DE19907489C1 (en) * 1999-02-16 2000-11-16 Eska Implants Gmbh & Co Hollow endoprosthesis
SE9900519D0 (en) * 1999-02-17 1999-02-17 Lars Lidgren A method for the preparation of UHMWPE doped with an antioxidant and an implant made thereof
GB9907843D0 (en) * 1999-04-06 1999-06-02 Connor John J O Compression moulding
US7186364B2 (en) * 2002-01-28 2007-03-06 Depuy Products, Inc. Composite prosthetic bearing constructed of polyethylene and an ethylene-acrylate copolymer and method for making the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879400A (en) * 1996-02-13 1999-03-09 Massachusetts Institute Of Technology Melt-irradiated ultra high molecular weight polyethylene prosthetic devices
US6245276B1 (en) * 1999-06-08 2001-06-12 Depuy Orthopaedics, Inc. Method for molding a cross-linked preform
US6566451B2 (en) * 2000-02-29 2003-05-20 Howmedica Osteonics Corp. Methods of improving the wear resistance of prosthetic medical devices
US6547828B2 (en) * 2001-02-23 2003-04-15 Smith & Nephew, Inc. Cross-linked ultra-high molecular weight polyethylene for medical implant use

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8426486B2 (en) 2004-02-03 2013-04-23 The General Hospital Corporation Highly crystalline cross-linked oxidation-resistant polyethylene
EP3111895A1 (en) 2004-02-03 2017-01-04 The General Hospital Corporation Highly crystalline cross-linked oxidation-resistant polyethylene
US9168683B2 (en) 2004-02-03 2015-10-27 The General Hospital Corporation Highly crystalline cross-linked oxidation-resistant polyethylene
WO2006013536A1 (en) * 2004-07-29 2006-02-09 De Villiers, Malan Annealing of radiation crosslinked polymers
US10925587B2 (en) 2005-05-20 2021-02-23 Neotract, Inc. Anchor delivery system
US11090036B2 (en) 2005-05-20 2021-08-17 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11504149B2 (en) 2005-05-20 2022-11-22 Teleflex Life Sciences Limited Median lobe destruction apparatus and method
US11471148B2 (en) 2005-05-20 2022-10-18 Teleflex Life Sciences Limited Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10945719B2 (en) 2005-05-20 2021-03-16 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US10575844B2 (en) 2005-05-20 2020-03-03 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10492792B2 (en) 2005-05-20 2019-12-03 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10426509B2 (en) 2005-05-20 2019-10-01 Neotract, Inc. Median lobe destruction apparatus and method
US10105132B2 (en) 2005-05-20 2018-10-23 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10299780B2 (en) 2005-05-20 2019-05-28 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US10143461B2 (en) 2005-05-20 2018-12-04 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US10195014B2 (en) 2005-05-20 2019-02-05 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10265061B2 (en) 2005-05-20 2019-04-23 Neotract, Inc. Latching anchor device
US8425815B2 (en) 2005-08-22 2013-04-23 The General Hospital Corporation Highly crystalline polyethylene
EP2441780A1 (en) 2005-08-22 2012-04-18 The General Hospital Corporation d/b/a Massachusetts General Hospital Highly Crystalline Polyethylene
US8420000B2 (en) 2005-08-22 2013-04-16 The General Hospital Corporation Highly crystalline polyethylene
EP2441782A1 (en) 2005-08-22 2012-04-18 The General Hospital Corporation d/b/a Massachusetts General Hospital Highly Crystalline Polyethylene
US9273189B2 (en) 2005-08-22 2016-03-01 The General Hospital Corporation Highly crystalline polyethylene
EP2441781A1 (en) 2005-08-22 2012-04-18 The General Hospital Corporation d/b/a Massachusetts General Hospital Highly crystalline polyethylene
EP2208739A1 (en) 2005-08-22 2010-07-21 The General Hospital Corporation d/b/a Massachusetts General Hospital Highly crystalline polyethylene
US10292801B2 (en) 2012-03-29 2019-05-21 Neotract, Inc. System for delivering anchors for treating incontinence
US11331093B2 (en) 2012-06-29 2022-05-17 Teleflex Life Sciences Limited Flexible system for delivering an anchor
US10130353B2 (en) 2012-06-29 2018-11-20 Neotract, Inc. Flexible system for delivering an anchor
CN102824232A (en) * 2012-08-28 2012-12-19 中国科学院宁波材料技术与工程研究所 Anti-oxidation artificial joint prosthesis and preparation method thereof
US10912637B2 (en) 2013-03-14 2021-02-09 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11850140B2 (en) 2013-03-14 2023-12-26 Teleflex Life Sciences Limited Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10349932B2 (en) 2013-03-15 2019-07-16 Neotract, Inc. Anchor delivery system
US11129608B2 (en) 2013-03-15 2021-09-28 Neotract, Inc. Anchor delivery system
US11672520B2 (en) 2017-12-23 2023-06-13 Teleflex Life Sciences Limited Expandable tissue engagement apparatus and method
US11298115B2 (en) 2020-08-03 2022-04-12 Teleflex Life Sciences Limited Handle and cartridge system for medical interventions
US11801041B2 (en) 2020-08-03 2023-10-31 Teleflex Life Sciences Limited Handle and cartridge system for medical interventions

Also Published As

Publication number Publication date
US20050146070A1 (en) 2005-07-07
AU2003245420A1 (en) 2004-01-06
AU2003245420A8 (en) 2004-01-06
WO2004000159A3 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
US20050146070A1 (en) Meta lback or mesh crosslinking
AU759013B2 (en) Low temperature pressure stabilization of implant component
CA2619942C (en) Oxidation resistant homogenized polymeric material
US7785508B2 (en) Method for producing medical implant or medical implant part
US6692679B1 (en) Cross-linked molded plastic bearings
JP4184872B2 (en) Continuously cross-linked polyethylene
CA2513538C (en) Methods for making oxidation resistant polymeric material
US20080178998A1 (en) Crosslinked polymeric composite for orthopaedic implants
EP0963824B1 (en) Method for forming cross-linked molded plastic bearings
AU742611B2 (en) Gamma irradiated heat treated implant for mechanical strength
EP2921186B1 (en) Annealing method for cross-linked polyethylene
AU4890400A (en) Two step gamma irradiation of polymeric bioimplant
EP1413414B1 (en) Method for forming cross-linked molded plastic bearings

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10518593

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP